\u7d2b\u91ce\u6b63\u4eba,\u00a0<\/span>\u5b89\u5ca1\u7fa9\u4eba,\u00a0<\/span>\u8fd1\u677e\u4e00\u6717.\u00a0<\/span>\u5c0f\u5150\u4e0a\u6c17\u9053\u72ed\u7a84\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff5e\u5589\u982d\u75be\u60a3\u3092\u4e2d\u5fc3\u306b\uff5e.\u00a0<\/span>\u5c0f\u5150\u8033\u00a038:291-296, 2017<\/span><\/p>\n<\/div>\n

 <\/p>\n<\/div>\n<\/div>\n<\/li>\n<\/ol>\n

\u8ad6\u6587\uff082016\uff09<\/h1>\n

\n
1. Takayasu Y, Shino M, Nikkuni O, Yoshida Y, Furuya N, Chikamatsu K. Oxygen-glucose deprivation increases firing of unipolar brush cells and enhances spontaneous EPSCs in Purkinje cells in the vestibule-cerebellum. Neurosci Res 2016; 106: 1-11.<\/li>\n
2. Yajima M, Nakajima K, Hirato J, Chikamatsu K. Extranodal soft tissue Rosai-Dorfman disease of the head and neck and its diagnositic difficulty. Auris Nasus Larynx 2016; 43(3): 345-9.<\/li>\n
3. Kaira K, Toyoda M, Shimizu A, Shino M, Sakakura K, Takayasu Y, Takahashi K, Asao T, Chikamatsu K. Expression of ER stress markers (GRP78\/BiP and PERK) in adenoid cystic carcinoma. Acta Otolaryngol 2016;\u00a0136(1):1-7.<\/li>\n
4. Kaira K, Toyoda M, Shimizu A, Imai H, Sakakura K, Nikkuni O, Suzuki M, Iijima M, Asao T, Chikamatsu K.\u00a0Prognostic significance of GRP78\/BiP expression in patients with Stage III\/IV hypopharyngeal squamous cell carcinoma.\u00a0Neoplasma. 2016;63(3):477-83.<\/li>\n
5. Takahashi H, Sakakura K, Mito I, Ida S, Chikamatsu K. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: immunomodulatory effects of chemotherapy. Cancer Science. 2016; 107(8): 1065-71.<\/li>\n
6. Sakakura K, Takahashi H, Kaira K, Toyoda M, Murata T, Ohnishi H, Oyama T, Chikamatsu K. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.\u00a0Lab Invest. 2016; 96(9): 994-1003.<\/li>\n
7. Kaira K, Toyoda M, Shimizu A, Imai H, Sakakura K, Nikkuni O, Suzuki M, Iijima M, Asao T, Chikamatsu K. Decreasing expression of glucose-regulated protein GRP78\/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma. Head Neck. 2016 Oct;38(10):1539-44.<\/li>\n
8. Okano Y, Satoh T, Horiguchi K, Toyoda M, Osaki A, Matsumoto S, Tomaru T, Nakajima Y, Ishii S, Ozawa A, Shibusawa N, Shimada T, Higuchi T, Chikamatsu K, Yamada M. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma. Endocr J. 2016 Oct 29;63(10):905-912.<\/li>\n
9. Sakakura K, Tazawa M, Otani N, Takagi M, Morita M, Kurosaki M, Chiyoda T, Kanai Y, Endo A, Murata T, Shino M, Yokobori Y, Shirakura K, Wada N, Chikamatsu K. Impact of a Multidisciplinary Round Visit for the Management of Dysphagia Utilizing a Wi-Fi-Based Wireless Flexible Endoscopic Evaluation of Swallowing. Ann Otol Rhinol Laryngol. 2017 Jan;126(1):47-53.<\/li>\n
10. Shirai K, Saitoh JI, Musha A, Abe T, Kobayashi D, Takakusagi Y, Takaysu Y, Shino M, Toyoda M, Takahashi K, Chikamatsu K, Ohno T, Nakano T. Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer. Anticancer Res. 2016 Dec;36(12):6571-6578.<\/li>\n
11. \u6851\u539f\u5e79\u592b, \u6a2a\u5800\u6709\u7d00, \u4e8c\u5bae\u6d0b, \u8fd1\u677e\u4e00\u6717. \u30af\u30ed\u30b9\u30dc\u30a6\u306b\u3088\u308b\u5185\u9838\u9759\u8108\u640d\u75c7\u4f8b. \u8033\u9f3b\u81e8\u5e8a 109(4): 281-286, 2016<\/li>\n
12. \u9ad8\u6a4b\u514b\u660c\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u5b5d\u5553\uff0c\u7d2b\u91ce\u6b63\u4eba\uff0c\u65b0\u570b\u6442\uff0c\u8c4a\u7530\u5b9f\uff0c\u9ad8\u5b89\u5e78\u5f18\uff0c\u8fd1\u677e\u4e00\u6717\uff0eSequential Chemoradiotherapy \u306b\u3088\u308bstage IV\u9032\u884c\u982d\u9838\u90e8\u764c33\u75c7\u4f8b\u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u65e5\u8033\u9f3b 119(5): 734-740, 2016<\/li>\n
13. \u9ad8\u6a4b\u514b\u660c, \u9ad8\u5b89\u5e78\u5f18, \u8fd1\u677e\u4e00\u6717. \u982d\u9838\u90e8\u764c\u306b\u304a\u3051\u308b\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u306e\u8a55\u4fa1. \u5317\u95a2\u6771\u533b\u5b66 66: 117-121, 2016<\/li>\n
14. \u65b0\u570b\u6442\uff0c\u9234\u6728\u653f\u7f8e\uff0c\u5ddd\u7530\u502b\u4e4b\uff0c\u6c5f\u53e3\u7d18\u592a\u90ce\uff0c\u5ca1\u7530\u9686\u5e73\uff0e\u53e3\u84cb\u6241\u6843\u8ee2\u79fb\u3092\u6765\u3057\u305f\u539f\u767a\u6027\u80ba\u764c\u4f8b\u3068\u305d\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\uff0e\u982d\u9838\u90e8\u764c 42(1): 34-38, 2016<\/li>\n
15. \u5fa1\u4efb\u4e00\u5149, \u9ad8\u6a4b\u79c0\u884c, \u8fd1\u677e\u4e00\u6717, \u4e8c\u5bae\u6d0b. \u54bd\u982d\u6f70\u760d\u3067\u767a\u75c7\u3057\u305f\u52a0\u9f62\u6027EBV\u967d\u6027\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b. \u53e3\u54bd\u79d1 29:225-230, 2016<\/li>\n
16. \u9ad8\u6a4b\u79c0\u884c, \u5fa1\u4efb\u4e00\u5149, \u8fd1\u677e\u4e00\u6717. \u767a\u71b1\u30fb\u54bd\u982d\u75db\u30fb\u9838\u90e8\u816b\u8139\u3067\u767a\u75c7\u3057\u305f\u54bd\u5f8c\u81bf\u760d\u4f8b\u3068\u5ddd\u5d0e\u75c5\u4f8b. \u53e3\u54bd\u79d1 29:219-224, 2016<\/li>\n
17. \u7d2b\u91ce\u6b63\u4eba\uff0c\u5b89\u5ca1\u7fa9\u4eba\uff0e\u5c0f\u5150\u6c17\u7ba1\u5207\u958b\uff08\u6c17\u7ba1\u958b\u7a93\uff09\u8853\u2015\u79c1\u306e\u8853\u5f0f\uff0e\u56a5\u4e0b\u533b\u5b66 5(2): 165-168, 2016<\/li>\n
18. \u9ad8\u6a4b\u79c0\u884c\uff0c\u5742\u5009\u6d69\u4e00\uff0c\u8fd1\u677e\u4e00\u6717\uff0e\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u764c\u95a2\u9023\u7dda\u7dad\u82bd\u7d30\u80de\u306e\u5f79\u5272\uff0e\u8033\u9f3b\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc 34(4)\uff1a211-219, 2016<\/li>\n
19. \u9ad8\u6a4b\u514b\u660c\uff0c\u76f8\u99ac\u771e\u7948\uff0c\u677e\u5c71\u654f\u4e4b\uff0c\u5de5\u85e4\u6bc5\uff0c\u8fd1\u677e\u4e00\u6717\uff0e\u8840\u7ba1\u5185\u6cbb\u7642\u3067\u6551\u547d\u3057\u305f\u984e\u52d5\u9759\u8108\u763b\u7834\u88c2\u75c7\u4f8b\uff0e\u65e5\u8033\u9f3b 119(12): 1516-1522, 2016<\/li>\n<\/ol>\n

     <\/p>\n

    \u8ad6\u6587\uff082015\uff09<\/h1>\n

    \n
    1. Takahashi H, Sakakura K, Kawabata-Iwakawa R, Rokudai S, Toyoda M, Nishiyama M, Chikamatsu K. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Cancer Immunol Immunother 2015;64:1407-1417.<\/li>\n
    2. Nikkuni O, Kaira K, Toyoda M, Shino M, Sakakura K, Takahashi K, Tominaga H, Oriuchi N, Suzuki M, Iijima M, Asao T, Nishiyama M, Nagamori S, Kanai Y, Oyama T, Chikamatsu K.\u3000 Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III\/IV Laryngeal Squamous Cell Carcinoma.\u3000Pathol Oncol Res 2015;21:1175-1181.<\/li>\n
    3. Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci 2015;106:1-8.<\/li>\n
    4. Okamiya T, Takahashi K, Kamada H, Hirato J, Motoi T, Fukumoto S, Chikamatsu K. Oncogenic osteomalacia caused by an occult paranasal sinus tumor. Auris Nasus Larynx 2015;42:167-169.<\/li>\n
    5. Yokobori Y, Toyoda M, Sakakura K, Kaira K, Tsushima Y, Chikamatsu K. 18F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma. Acta Otolaryngol 2015;135:494-449.<\/li>\n
    6. Musha A, Shimada H, Shirai K, Saitoh J, Yokoo S, Chikamatsu K, Ohno T, Nakano T. Prediction of acute radiation mucositis using an oral mucosal dose surface model in carbon ion radiotherapy for head and neck tumors. PLoS ONE 2015; 10: e0141734.<\/li>\n
    7. \u9ad8\u6a4b\u514b\u660c, \u5ca1\u672c\u5f69\u5b50, \u65b0\u570b\u6442, \u5ca1\u5bae\u667a\u53f2, \u7d2b\u91ce\u6b63\u4eba, \u9ad8\u5b89\u5e78\u5f18, \u8fd1\u677e\u4e00\u6717. \u553e\u6db2\u4e2d\u30d8\u30eb\u30da\u30b9\u30a6\u30a4\u30eb\u30b9DNA\u6e2c\u5b9a\u306b\u3088\u308b\u30e1\u30cb\u30a8\u30fc\u30eb\u75c5\u767a\u4f5c\u671f\u306e\u8089\u4f53\u7684\u75b2\u52b4\u6e2c\u5b9a\u306e\u8a66\u307f. Equilibrium Res 74:8-14, 2015<\/li>\n
    8. \u9234\u6728\u653f\u7f8e\uff0c\u65b0\u570b\u6442\uff0c\u6c5f\u53e3\u7d18\u592a\u90ce\uff0c\u5ddd\u7530\u502b\u4e4b\uff0e\u53e3\u8154\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u984e\u4e0b\u817a\u8ee2\u79fb\u30fb\u984e\u4e0b\u817a\u6d78\u6f64\u306e\u691c\u8a0e\uff0e\u982d\u9838\u90e8\u5916\u79d1 24(3): 279-284\uff0c2015<\/li>\n
    9. \u5ca1\u5bae\u667a\u53f2, \u5bae\u4e0b\u5143\u660e, \u5ba4\u4e95\u660c\u5f66, \u5e73\u6238\u7d14\u5b50, \u8fd1\u677e\u4e00\u6717. \u54bd\u5f8c\u81bf\u760d\u3092\u4f75\u767a\u3057\u305f\u4f1d\u67d3\u6027\u5358\u6838\u7403\u75c7\u4f8b. \u8033\u9f3b\u81e8\u5e8a 108:201-205, 2015<\/li>\n
    10. \u9ad8\u6a4b\u514b\u660c, \u4e2d\u5cf6\u606d\u5b50, \u7d2b\u91ce\u6b63\u4eba, \u8c4a\u7530\u5b9f, \u9ad8\u5b89\u5e78\u5f18, \u8fd1\u677e\u4e00\u6717. \u907a\u4f1d\u5b50\u691c\u67fb\u306b\u3088\u308b\u5f8c\u767a\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u306e\u4e88\u6e2c. \u65e5\u8033\u9f3b 118:135-139, 2015<\/li>\n
    11. \u9ad8\u6a4b\u514b\u660c\uff0e\u3010\u30b9\u30c8\u30ec\u30b9\u3068\u8033\u9f3b\u54bd\u5589\u79d1\u30fb\u982d\u9838\u90e8\u5916\u79d1\u3011 \u30b9\u30c8\u30ec\u30b9\u3068\u53e3\u5185\u708e\uff0eJOHNS 31(3): 329-333, 2015<\/li>\n
    12. \u8fd1\u677e\u4e00\u6717. Current Organ Topics: Head and Neck Tumor \u982d\u9838\u90e8\u816b\u760d II. \u982d\u981a\u90e8\u306b\u5bfe\u3059\u308b\u514d\u75ab\u7642\u6cd5. \u764c\u3068\u5316\u5b66\u7642\u6cd5 42:802-805, 2015<\/li>\n
    13. \u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u9818\u57df\u306e\u795e\u7d4c\u75db\u3000\u7279\u96c6\u3000\u3000\u8033\u9f3b\u54bd\u5589\u79d1\u306e\u75be\u60a3\u30fb\u75c7\u4f8b\u5225\u85ac\u7269\u7642\u6cd5\u3000JOHNS\u3000Vol.31 No.9 \u5897\u5927\u53f7\u3000\u8033\u9f3b\u54bd\u5589\u79d1\u85ac\u7269\u7642\u6cd52015<\/li>\n
    14. \u7d2b\u91ce\u6b63\u4eba\u3000\u6c17\u7ba1\u98df\u9053\u9818\u57df\u306e\u5c0f\u5150\u6c17\u9053\u75be\u60a3\u3078\u306e\u5bfe\u5fdc\u3000\u7b2c66\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3000\u6c17\u98df66\uff082\uff09109-111\u30012015<\/li>\n
    15. \u5b89\u5ca1\u7fa9\u4eba\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u96fb\u5b50\u5185\u8996\u93e1\u3067\u8a3a\u308b\u5c0f\u5150\u9f3b\u51fa\u8840\u306e\u8840\u7ba1\u75c5\u614b\u3068\u6b62\u8840\u6cd5\u306e\u5de5\u592b-\u6bcd\u6307\u5727\u8feb\u6b62\u8840\u6cd5\uff08thumb press maneuver: TPM\uff09\uff0e\u5c0f\u5150\u8033 36(3): 374-380\uff0c2015<\/li>\n
    16. \u6c5f\u53e3\u7d18\u592a\u90ce\uff0c\u9234\u6728\u653f\u7f8e\uff0c\u4e95\u7530\u7fd4\u592a\uff0c\u5ddd\u7530\u502b\u4e4b\uff0c\u5ca1\u7530\u9686\u5e73\uff0c\u65b0\u570b\u6442\uff0c\u671d\u852d \u5b5d\u5b8f\uff0e\u5074\u9838\u56a2\u80de\u304a\u3088\u3073\u56a2\u80de\u72b6\u8ee2\u79fb\u6027\u30ea\u30f3\u30d1\u7bc0\u306e\u5185\u5bb9\u6db2\u30a2\u30df\u30e9\u30fc\u30bc\u30fb\u30b5\u30a4\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u6e2c\u5b9a\u306b\u3088\u308b\u9451\u5225\u8a3a\u65ad\uff0e\u982d\u9838\u90e8\u764c 41(3): 335-338\uff0c2015<\/li>\n
    17. \u571f\u5e2b\u77e5\u884c\u3001\u5ca9\u6c38\u5065\u3001\u5343\u4ee3\u7530\u670b\u5b50\u3001\u5927\u91ce\u6052\u4e45\u3000\u8033\u5185\u3088\u308a\u8a18\u9332\u3057\u305f\u56a5\u4e0b\u97f3\u306b\u3064\u3044\u3066\uff0d\u5065\u5e38\u8005\u306b\u304a\u3051\u308b\u4e88\u5099\u7684\u7814\u7a76\uff0d\u3000\u65e5\u6c17\u98df\u4f1a\u583166\uff081\uff09\uff1a13-19, 2015<\/li>\n<\/ol>\n

         <\/p>\n

        \u8ad6\u6587\uff082014\uff09<\/h1>\n

        \n
        1. Shino M, Yasuoka Y, Nakajima K, Chikamatsu K. A case of pyriform sinus fistula infection with double tracts. Case Rep Otolaryngol 2014;2014:126840.<\/li>\n
        2. Toyoda M, Kaira K, Shino M, Sakakura K, Takahashi K, Takayasu Y, Tominaga H, Oriuchi N, Nikkuni O, Suzuki M, Iijima M, Tsukamoto N, Nagamori S, Kanai Y, Oyama T,\u00a0Chikamatsu K. CD98 is a novel prognostic indicator for patients with stage III\/IV hypopharyngeal squamous cell carcinoma. Head Neck. 2015; 37(11):1569-74.<\/li>\n
        3. Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, Takayasu Y, Takahashi K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer 2014;110:2506-2513<\/li>\n
        4. Kayakabe M, Takahashi K, Okamiya T, Segawa A, Oyama T, Chikamatsu K. Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriated secretion of antidiuretic hormone. Oncol. Lett. 2014;7:1253-1256.<\/li>\n
        5. Kayakabe M, Kakizaki T, Kaneko R, Sasaki A, Nakazato Y, Shibasaki K, Ishizaki Y, Saito H, Suzuki N, Furuya N, Yanagawa Y. Motor dysfunction in cerebellar Purkinje cell-specific vesicular GABA transporter knockout mice. Front Cell Neurosci. 2014 Jan 16;7:286.<\/li>\n
        6. Suzuki M, Tsunoda A, Kudo T, Okada R, Toyoda M: Successful management of hypoparathyroidism following total thyroidectomy with vitamin D3 alone.\u3000Auris Nasus Larynx 41(1): 53-55, 2014<\/li>\n
        7. \u8fd1\u677e\u4e00\u6717\u3000\u753b\u50cf\u8a3a\u65ad\u30d1\u30fc\u30d5\u30a7\u30af\u30c8\u30ac\u30a4\u30c9\u2015\u7279\u6b8a\u306a\u60aa\u6027\u816b\u760d\u3000\u8033\u9f3b\u54bd\u5589\u79d1\u30fb\u982d\u9838\u90e8\u5916\u79d1\u300086\uff085\uff09\uff1a156-162\u30012014<\/li>\n
        8. \u8fd1\u677e\u4e00\u6717\u3000\u514d\u75ab\u7642\u6cd5\u3000\u8033\u9f3b\u3068\u81e8\u5e8a60\u5dfb\u88dc\u518a\uff11\u53f7\uff1aS63-69, 2014<\/li>\n
        9. \u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u6c17\u7ba1\u5f01\u6cd5\uff1a\u5b89\u5ca1\u7fa9\u4eba\u306e\u8853\u5f0f\u3000\u56a5\u4e0b\u533b\u5b66\u30003(2)\uff1a219-223\u30012014<\/li>\n
        10. \u661f\u91ce\u7adc\u3001\u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9aa8\u9ac4\u79fb\u690d\u5f8c\u306b\u767a\u75c7\u3057\u305f\u53e3\u8154\u5185\u7570\u6642\u6027\u591a\u91cd\u764c\u306e1\u75c7\u4f8b\u3000\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u96d1\u8a8c27\uff081\uff09\uff1a63-68\u30012014<\/li>\n
        11. \u4e94\u5473\u6681\u61b2\u3001\u6a2a\u5c3e\u8061\u3001\u795e\u6238\u667a\u5e78\u3001\u6cb3\u5185\u5948\u7a42\u5b50\u3001\u5bae\u5d0e\u82f1\u9686\u3001\u7267\u53e3\u8cb4\u54c9\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e2d\u54bd\u982d\u764c\u8853\u5f8c\u306b\u9f3b\u54bd\u8154\u9589\u9396\u6a5f\u80fd\u4e0d\u5168\u306b\u5bfe\u3057bulb-PLP\u3092\u9069\u5fdc\u3057\u305f1\u4f8b\u3000\u982d\u9838\u90e8\u764c40\uff0830\uff09\uff1a385-390,2014<\/li>\n
        12. \u5742\u672c\u9032\u3001\u5927\u91ce\u6052\u4e45\u3001\u5bae\u5d0e\u62d3\u4e5f\u3001\u5343\u4ee3\u7530\u670b\u5b50\u3001\u4f50\u85e4\u9032\u4e00\u3000\u53e3\u8154\u764c\u306b\u5bfe\u3059\u308b\u518d\u5efa\u8853\u5f8c\u306b\u76ae\u5f01\u767a\u764c\u3092\u751f\u3058\u305f2\u4f8b\u3000\u8033\u9f3b\u81e8\u5e8a107\uff1a11\uff1b913-917\u30012014<\/li>\n
        13. \u5bae\u5d0e\u9054\u4e5f, \u5b97\u7530\u3000\u771f, \u9152\u4e95\u3000\u771f, \u9ad8\u6a4b\u514b\u660c, \u8fd1\u677e\u4e00\u6717, \u6851\u91ce\u535a\u884c. \u4e0b\u54bd\u982d\u30fb\u98df\u9053\u91cd\u8907\u764c\u306e\u53d6\u308a\u6271\u3044\u2015\u98df\u9053\u91cd\u8907\u764c\u306e\u73fe\u72b6\u3068\u6cbb\u7642\u6226\u7565\u3000\u98df\u9053\u764c\u8a3a\u7642\u306e\u7acb\u5834\u304b\u3089\u3000\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u3000\u5c02\u9580\u533b\u901a\u4fe1\u300049:18-23, 2014<\/li>\n<\/ol>\n

             <\/p>\n

            \u8ad6\u6587\uff082013\uff09<\/h1>\n

            \n
            1. Masato Shino, MD; Yoshihito Yasuoka, MD; Takaaki Murata, MD; Hiroshi Ninomiya, MD; Yukihiro Takayasu, MD; Katsumasa Takahashi, MD; Kazuaki Chikamatsu, MD Improvement of Tracheal Flap Method for Laryngotracheal Separation. The Laryngoscope 123(2):440-445, 2013<\/li>\n
            2. Chikamatsu K, Ishii H, Murata T, Sakakura K, Shino M, Toyoda M, Takahashi K, Masuyama K. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. Cancer Sci. 2013;104:1468-1475.<\/li>\n
            3. Murata T, Shino M, Yasuoka Y, Chikamatsu K\u3000Subglottic Schwannoma: A report of a rare case that was treated with medial thyrotomy. Am J Otolaryngol. 34\uff1a569-573, 2013<\/li>\n
            4. Koichi Sakakura, Kazuaki Chikamatsu Immune suppression and evasion in patients with head and neck cancer. Advances in Cellular and Molecular Otolaryngology 2013, 1: 21809<\/li>\n
            5. Shimada T, Kamada H, Hoshino R, Okamiya T, Takahashi K, Chikamatsu K. Development of a new method using narrow band imaging for taste assessment. Laryngoscope 2013;123:2405-2410.<\/li>\n
            6. Kaira K, Toyoda M, Shino M, Sakakura K, Takahashi K, Tominaga H, Oriuchi N, Kanai Y, Oyama T, Chikamatsu K. Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma. Pathol. Oncol. Res. (2013) 19:649\u2013656, 2013<\/li>\n
            7. Igarashi S, Chikamatsu K, Miyata M, Maenosono M, Yonaga T, Nakazawa T, Katoh R, Masuyama K. Epithelial-myoepithelial carcinoma of the parotid gland: a case report and immunohistochemical analysis. Yamanashi Med. J. 2013;27:71-78.<\/li>\n
            8. \u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u764c\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u3000\u8033\u9f3b\u81e8\u5e8a106\uff1a2\uff1b184-185, 2013<\/li>\n
            9. \u8fd1\u677e\u4e00\u6717\u3000\u56f3\u3067\u307f\u308b\u514d\u75ab\u5b66\u306eABC \u816b\u760d\u3068\u514d\u75ab \u816b\u760d\u306b\u5bfe\u3059\u308b\u514d\u75ab\u5fdc\u7b54. JOHNS 29(3), 460-464, \u6771\u4eac\u533b\u5b66\u793e, 2013.<\/li>\n
            10. \u5b89\u5ca1\u7fa9\u4eba\u3001\u4e2d\u5cf6\u606d\u5b50\u3000\u7279\u96c6\u30fb\u8033\u9f3b\u54bd\u5589\u79d1\u306b\u304a\u3051\u308b\u4e73\u5e7c\u5150\u8a3a\u7642Q&A\u3000\u5148\u5929\u6027\u4e0a\u6c17\u9053\u72ed\u7a84\u306e\u75c5\u9662\u30fb\u75c5\u614b\u5225\u6cbb\u7642\u65b9\u91dd\u3092\u793a\u3057\u3066\u304f\u3060\u3055\u3044\u3000MB ENT. 152\uff1a65-71,2013<\/li>\n
            11. \u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u6c17\u9053\u78ba\u4fdd\u306e\u5f8c\u907a\u75c7\u3000JOHNS 26(10):1749-1752, 2013<\/li>\n
            12. \u6751\u7530\u8003\u5553\u3001\u5cf6\u7530\u54f2\u660e\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u65bd\u884c\u4f8b\u306b\u304a\u3051\u308b\u97f3\u58f0\u969c\u5bb3\u306e\u81ea\u899a\u7684\u8a55\u4fa1\u306e\u691c\u8a0e\u3000\u5589\u982d25\uff1a83-86\u30012013<\/li>\n<\/ol>\n

                 <\/p>\n

                \u8ad6\u6587\uff082012\uff09<\/h1>\n

                \n
                1. Shino M, R. Kaneko, Y. Yanagawa, Y. Kawaguchi and Y. Saito: Electrophysiological characteristics of inhibitory neurons of the prepositus hypoglossi nucleus as\u3000analyzed in venus-expressing transgenic rats.\u3000Neuroscience 197: 89\u201398, 2011.<\/li>\n
                2. Chikamatsu K, Ishii H, Takahashi, G, Okamoto A, Moriyama M, Sakakura K, Masuyama K. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck 34:336-343, 2012.<\/li>\n
                3. Chikamatsu K, Sakakura K, Toyoda M, Takahashi K, Yamamoto T, Masuyama K. Immunosuppressive activity of CD14+HLA-DR- cells in squamous cell carcinoma of the head and neck. Cancer Sci 103(6):976-983, 2012<\/li>\n
                4. Saito Y, Shino M, Yanagawa Y. Characterization of ionic channels underlying the specific firing pattern of a novel neuronal subtype in the rat prepositus hypoglossi nucleus. Neurosci Res. 73:32-41, 2012<\/li>\n
                5. Yoshimoto S, Hasegawa Y, Matsuzuka T, Shiotani A, Takahashi K, Kohno N, Yoshida T,Kitano H. Sentinel node biopsy for oral and laryngopharyngeal squamous cell carcinoma: A retrospective study of 177 patients in Japan. Auris Nasus Larynx, 39: 65-70, 2012<\/li>\n
                6. Matsuzaki T, Takahashi K, Kawakita D, Kohono N, Nagafuji H, Yamauchi K, Suzuki M, Miura T, Furuya N, Yatabe Y, Matsuo K, Omori K, Hasegawa Y. Intraoperative molecular assessment for lymph node metastasis in head and neck squamous cell carcinoma using one-step nucleic acid amplification(OSNA) assay. Ann Surg Oncol. 19(12): 3865-70, 2012<\/li>\n
                7. \u8fd1\u677e\u4e00\u6717\u3001\u5897\u5c71\u656c\u7950\u3000\u304c\u3093\u514d\u75ab\u7642\u6cd5\u306b\u95a2\u3059\u308b\u6700\u8fd1\u306e\u8a71\u984c\u3000\u8033\u9f3b\u81e8\u5e8a\u3000105\uff1a2\uff1b87-94, 2012<\/li>\n
                8. \u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u764c\u5e79\u7d30\u80de\u3068\u305d\u306e\u6cbb\u7642\u6226\u7565\u3000\u8033\u9f3b\u54bd\u5589\u79d1\u30fb\u982d\u9838\u90e8\u5916\u79d1\u300084\u5dfb\uff086\uff09\uff1a335-344, 2012<\/li>\n
                9. \u8fd1\u677e\u4e00\u6717. \u816b\u760d\u514d\u75ab\u3068\u305d\u306e\u81e8\u5e8a\u5fdc\u7528. Kitakanto Med J 62:335-336, 2012<\/li>\n
                10. \u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u764c\u306b\u304a\u3051\u308bMyeloid-derived suppressor cell \u306e\u679c\u305f\u3059\u5f79\u5272\u3000\u8033\u9f3b\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\uff08JJIAO\uff0930\uff084\uff09: 271\u2015278, 2012<\/li>\n
                11. \u5b89\u5ca1\u7fa9\u4eba\u3001\u5cf6\u7530\u54f2\u660e\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u98ef\u7530\u82f1\u57fa\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS\uff09\uff0d\u8853\u524d\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3068\u624b\u8853\u306e\u30b3\u30c4\u2015\u3000\u5589\u982d\u300024(2):109\uff65115\u30012012<\/li>\n
                12. \u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7279\u6b8a\u75be\u60a3\u8a3a\u7642NAVI, 3.Wegener\u8089\u82bd\u816b\u75c7. \u8033\u5589\u982d\u9838\u300084:339-343, 2012<\/li>\n
                13. \u9234\u6728\u653f\u7f8e\u3001\u5de5\u85e4\u6bc5\u3001\u5ca1\u7530\u9686\u5e73\u3001\u8c4a\u7530\u5b9f\u3001\u5ca1\u672c\u5f69\u5b50\u3000\u4e21\u9838\u90e8\u90ed\u6e05\u3068\u7532\u72b6\u817a\u65b9\u8449\u5207\u9664\u3092\u65bd\u884c\u3057\u305f\u4e0b\u54bd\u982d\u764c\u306e\u526f\u7532\u72b6\u817a\uff08\u4e0a\u76ae\u5c0f\u4f53\uff09\u6a5f\u80fd\u6e29\u5b58\u306b\u3064\u3044\u3066\u3000\u982d\u9838\u90e8\u5916\u79d1\u300022\uff082\uff09\uff1a203-208,2012<\/li>\n<\/ol>\n

                     <\/p>\n

                    \u8ad6\u6587\uff082011\uff09<\/h1>\n

                    \n
                    1. Murata T., Yasuoka Y., Shimada T., Shino M., Iida H., Takahashi T., Furuya N. A new and less invasive procedure for arytenoid adduction surgery: Endoscopic-assisted Arytenoid Adduction Surgery. The laryngoscope, 121, 1274-1280, 2011<\/li>\n
                    2. Masato Shino, MD, Katsumasa Takahashi, MD, Takaaki Murata, MD, Hideki Iida, MD, Yoshihito Yasuoka, MD, Nobuhiko Furuya, MD, PhD Angiotensin II receptor blocker\u2013induced angioedema in the oral floor and epiglottis Am J Otolaryngol. 32 624\u2013626, 2011<\/li>\n
                    3. Kazuhiro Mitsumura, Nobutake Hoshi, Nobuhiko Furuya and Hirokazu Hirai Disruption of metabotropic glutamate receptor signaling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice J Physiol 589(Pt13):3191-209, 2011 May<\/li>\n
                    4. \u5b89\u5ca1\u7fa9\u4eba, \u4e8c\u5bae\u6d0b, \u7d2b\u91ce\u6b63\u4eba\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853(\u6c17\u7ba1\u5f01\u6cd5)\u306e\u8853\u5f0f\u3068\u305d\u306e\u5229\u70b9\u3000\u5c0f\u5150\u5916\u79d1(0385-6313)43\u5dfb3\u53f7 Page283-287(2011.03)<\/li>\n<\/ol>\n

                        <\/p>\n

                       \u5b66\u4f1a\u767a\u8868\uff082015\u5e74\u5ea6\uff09<\/h1>\n

                       \n
                       1. \u5b89\u5ca1\u7fa9\u4eba\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u96fb\u5b50\u5185\u8996\u93e1\u3067\u8a3a\u308b\u5c0f\u5150\u9f3b\u51fa\u8840\u306e\u8840\u7ba1\u75c5\u614b\u3068\u6b62\u8840\u6cd5\u306e\u5de5\u592b\u3000\u7b2c\u3000\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a5\/8-9\uff08\u8efd\u4e95\u6ca2\uff09<\/li>\n
                       2. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u65b0\u56fd\u6442\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u658e\u85e4\u6df3\u4e00\u3001\u767d\u4e95\u514b\u5e78\u3001<\/li>\n
                       3. \u5927\u91ce\u9054\u4e5f\u3001\u4e2d\u91ce\u9686\u53f2\u3000\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u60aa\u6027\u816b\u760d\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306e\u77ed\u671f\u6210\u7e3e\u3000\u7b2c116\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/20-23\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                       4. \u8fd1\u677e\u4e00\u6717\u3001\u9ad8\u6a4b\u79c0\u884c\u3001\u5742\u5009\u6d69\u4e00\u3001\u5ca1\u672c\u5f69\u5b50\u3000\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u60a3\u8005\u672b\u68a2\u8840\u4e2d\u306e\u5faa\u74b0\u764c\u7d30\u80de\u306e\u540c\u5b9a\u3068\u81e8\u5e8a\u7684\u610f\u7fa9\u3000\u7b2c116\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/20-23\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                       5. \u9ad8\u6a4b\u79c0\u884c\u3001\u4e95\u7530\u7fd4\u592a\u3001\u5fa1\u4efb\u4e00\u5149\u3001\u5ca1\u672c\u5f69\u5b50\u3001\u5742\u5009\u6d69\u4e00\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u514d\u75ab\u7d30\u80de\u30b5\u30d6\u30bb\u30c3\u30c8\u306e\u5909\u5316\u3068\u5316\u5b66\u7642\u6cd5\u306e\u514d\u75ab\u52d5\u614b\u3078\u306e\u95a2\u4e0e\u3000\u7b2c116\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/20-23\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                       6. Kazuaki Chikamatsu\u3000Carbon ion radiotherapy with concurrent chemotherapy for head and neck mucosal melanoma\uff08\u982d\u9838\u90e8\u7c98\u819c\u60aa\u6027\u9ed2\u8272\u816b\u306b\u5bfe\u3059\u308b\u5316\u5b66\u7642\u6cd5\u4f75\u7528\u70ad\u7d20\u30a4\u30aa\u30f3\u7dda\u6cbb\u7642\uff09\u7b2c39\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u306a\u3089\u3073\u306b\u7b2c4\u56de\u30a2\u30b8\u30a2\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30006\/3-6\uff08\u795e\u6238\uff09<\/li>\n
                       7. Koichi Sakakura, et al. Relation between Tumor-associated Macrophage Subsets and CD47\u7b2c39\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u306a\u3089\u3073\u306b\u7b2c4\u56de\u30a2\u30b8\u30a2\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30006\/3-6\uff08\u795e\u6238\uff09<\/li>\n
                       8. Osamu Nikkuni, et al.\u3000Evaluation of Ultrasound Elastography for the Diagnosis of Salivary Gland Tumors\u7b2c39\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u306a\u3089\u3073\u306b\u7b2c4\u56de\u30a2\u30b8\u30a2\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30006\/3-6\uff08\u795e\u6238\uff09<\/li>\n
                       9. Hideyuki Takahashi, et al.\u3000The Alteration of Immune Effector and Suppressor Cells in Head and Neck\u3000Squamous Cell Carcinoma\u3000\u7b2c39\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u306a\u3089\u3073\u306b\u7b2c4\u56de\u30a2\u30b8\u30a2\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30006\/3-6\uff08\u795e\u6238\uff09<\/li>\n
                       10. \u591a\u7530\u7d18\u6075\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e0a\u984e\u6d1e\u539f\u767a\u306e\u80ba\u5916\u6df7\u5408\u578b\u5c0f\u7d30\u80de\u764c\u306e\u4e00\u4f8b\u3000\u7b2c110\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/14\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                       11. \u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u8fd1\u677e\u4e00\u6717\uff08\u7fa4\u99ac\u5927\uff09\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3000\u7fa4\u99ac\u770c\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u8074\u899a\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u73fe\u6cc1\u3000\u7b2c110\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/14\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                       12. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u9662\u306b\u3066\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u884c\u3063\u305f\u982d\u9838\u90e8\u60aa\u6027\u816b\u760d\u5168104\u75c7\u4f8b\u306e\u307e\u3068\u3081\u3000\u7b2c110\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/14\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                       13. \u9ad8\u6a4b\u514b\u660c\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7d30\u83cc\u907a\u4f1d\u5b50\u691c\u67fb\u306b\u3088\u308b\u8033\u8853\u5f8c\u611f\u67d3\u306e\u8fc5\u901f\u540c\u5b9a\u3000\u7b2c110\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/14\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                       14. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u96e3\u6cbb\u6027\u8033\u7ba1\u958b\u653e\u75c7\u306b\u5bfe\u3059\u308b\u8033\u7ba1\u5185\u30eb\u30b4\u30fc\u30eb\u5857\u5e03\u6ce8\u5165\u7642\u6cd5\u306e\u4e00\u5de5\u592b\uff0d\u30eb\u30b4\u30fc\u30eb\u7dbf\u68d2\u30d6\u30b8\u30fc\u6cd5\uff0d\u3000\u7b2c110\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/14\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                       15. \u5fa1\u4efb\u4e00\u5149\u3001\u4e95\u7530\u7fd4\u592a\u3001\u77e2\u5cf6\u7f8e\u9999\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u6c17\u9053\u71b1\u50b7\u5f8c\u306e\u6c17\u7ba1\u633f\u7ba1\u306b\u3088\u308a\u5f62\u6210\u3055\u308c\u305f\u58f0\u9580\u4e0b\u8089\u82bd\u306e\uff11\u4f8b\u3000\u7b2c77\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/25-26\uff08\u6d5c\u677e\u5e02\uff09<\/li>\n
                       16. \u4e95\u7530\u7fd4\u592a\u3001\u5fa1\u4efb\u4e00\u5149\u3001\u77e2\u5cf6\u7f8e\u9999\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e0a\u54bd\u982d\u816b\u760d\u304b\u3089\u5185\u981a\u52d5\u8108\u72ed\u7a84\u306b\u3088\u308b\u8133\u6897\u585e\u3092\u767a\u75c7\u3057\u305f1\u4f8b\u3000\u7b2c77\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/25-26\uff08\u6d5c\u677e\u5e02\uff09<\/li>\n
                       17. Koichi Sakakura, Hideyuki Takahashi, Kyoichi Kaira, Minoru Toyoda, Kazuaki Chikamatsu Possible relation between tumor-associated macrophage (TAM) subsets and CD47 expression on squamous cell carcinoma of the head and neck (SCCHN) in tumor microenvironment International Conference of Cancer Immunotherapy and Macrophages 2015 9^{th<\/sup>-11th<\/sup>\u00a0July (Tokyo)<\/li>\n}
                       18. \u4e2d\u5cf6\u606d\u5b50\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u5148\u5929\u6027\u6a2a\u9694\u819c\u30d8\u30eb\u30cb\u30a2\u306e\u65e2\u5f80\u304c\u3042\u308b\u96e3\u8074\u51507\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c4\u56de\u5c0f\u5150\u8a3a\u7642\u591a\u7a2e\u7814\u7a76\u4f1a\u30007\/19-20\uff08\u5317\u4e5d\u5dde\uff09<\/li>\n
                       19. \u5fa1\u4efb\u4e00\u5149\u3001\u9ad8\u6a4b\u79c0\u884c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u6f70\u760d\u3067\u767a\u75c7\u3057\u305f\u52a0\u9f62\u6027EBV\u967d\u6027\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\uff11\u4f8b\u3000\u7b2c28\u56de\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/10-11\uff08\u5927\u962a\u5e02\uff09<\/li>\n
                       20. \u9ad8\u6a4b\u79c0\u884c\u3001\u5fa1\u4efb\u4e00\u5149\u3001\u8fd1\u677e\u4e00\u6717\u3000\u767a\u71b1\u30fb\u54bd\u982d\u75db\u30fb\u9838\u90e8\u816b\u8139\u3067\u767a\u75c7\u3057\u305f\u54bd\u5f8c\u81bf\u816b\u75c7\u4f8b\u3068\u5ddd\u5d0e\u75c5\u75c7\u4f8b\u3000\u7b2c28\u56de\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/10-11\uff08\u5927\u962a\u5e02\uff09<\/li>\n
                       21. \u65b0\u570b\u3000\u6442\uff0c\u938c\u7530\u82f1\u7537\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u55c5\u899a\u8131\u5931\u60a3\u8005\u306b\u304a\u3051\u308bn\ufe32\u30d7\u30ed\u30d4\u30eb\u30e1\u30eb\u30ab\u30d7\u30bf\u30f3\u8a8d\u77e5\u691c\u67fb\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066\u3000\u7b2c54\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u300010\/1-3\uff08\u5e83\u5cf6\u5e02\uff09<\/li>\n
                       22. \u897f\u5ca1\u7531\u6a39\uff0c\u9ad8\u6a4b\u514b\u660c\uff0c\u8fd1\u677e\u4e00\u6717\uff0c\u5e73\u6238\u7d14\u5b50\uff0c\u6a2a\u5c3e\u82f1\u660e\u3000\u4e0a\u984e\u6d1e\u539f\u767aOncocytic Schneiderian papilloma\u306e\u4e00\u4f8b\u3000\u7b2c54\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u300010\/1-3\uff08\u5e83\u5cf6\u5e02\uff09<\/li>\n
                       23. \u9ad8\u6a4b\u514b\u660c\uff0c\u897f\u5ca1\u7531\u6a39\uff0c\u8fd1\u677e\u4e00\u6717\uff0c\u767d\u4e95\u514b\u5e78\uff0c\u9f4b\u85e4\u6df3\u4e00\uff0c\u5927\u91ce\u9054\u4e5f\uff0c\u4e2d\u91ce\u9686\u53f2\u3000\u91cd\u7c92\u5b50\u7dda\u306b\u3088\u308b\u55c5\u795e\u7d4c\u82bd\u7d30\u80de\u816b\u306e\u6cbb\u7642\u7d4c\u9a13\u3000\u7b2c54\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u300010\/1-3\uff08\u5e83\u5cf6\u5e02\uff09<\/li>\n
                       24. \u9ad8\u6a4b\u79c0\u884c\u3001\u5742\u5009\u6d69\u4e00\u3001\u8fd1\u677e\u4e00\u6717Cancer-associated fibroblasts induce immunosuppressive macrophages in head and neck squamous cell carcinoma (\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u764c\u95a2\u9023\u7dda\u7dad\u82bd\u7d30\u80de\u306f\u514d\u75ab\u6291\u5236\u6027\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u3092\u8a98\u5c0e\u3059\u308b \u7b2c74\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u300010\/8-10\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                       25. \u5742\u5009\u6d69\u4e00\u3001\u9ad8\u6a4b\u79c0\u884c\u3001\u8fd1\u677e\u4e00\u6717Significance of differential white blood cell counts on nutrition in oropharyngeal cancer patients with chemoradiation (\u4e2d\u54bd\u982d\u764c\u306b\u5bfe\u3059\u308b\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306b\u304a\u3051\u308b\u6442\u98df\u30fb\u6804\u990a\u30d1\u30e9\u30e1\u30fc\u30bf\u306b\u5bfe\u3059\u308b\u767d\u8840\u7403\u5206\u753b\u306e\u610f\u7fa9) \u7b2c74\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u300010\/8-10\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                       26. \u7d2b\u91ce\u6b63\u4eba\uff0c\u8c4a\u7530\u5b9f\u3001\u6751\u7530\u8003\u5553\u3001\u5bae\u5d0e\u9054\u4e5f\u3001\u5b97\u7530\u771f\u3001\u9152\u4e95\u771f\u3001\u6851\u91ce\u535a\u884c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8d64\u5916\u7dda\u30b5\u30fc\u30e2\u30b0\u30e9\u30d5\u30a3\u306b\u3088\u308b\u904a\u96e2\u7a7a\u8178\u518d\u5efa\u5f8c\u30fb\u30e2\u30cb\u30bf\u30fc\u7a7a\u8178\u306e\u72b6\u6cc1\u5224\u65ad\u3000\u7b2c67\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300011\/19-20\u3000(\u798f\u5cf6\u5e02)<\/li>\n
                       27. \u9ad8\u6a4b\u514b\u660c\uff0c\u65b0\u570b\u6442\uff0c\u5ca1\u5bae\u667a\u53f2\uff0c\u9ad8\u5b89\u5e78\u5f18\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u8996\u904b\u52d5\u6027\u773c\u632f\u306b\u5bfe\u3059\u308b\u91cd\u529b\u60c5\u5831\u306e\u5f71\u97ff\u3000\u7b2c74\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/25-27\u3000\uff08\u5c90\u961c\u5e02\uff09<\/li>\n
                       28. \u8fd1\u677e\u4e00\u6717\uff0c\u5143\u5ddd\u7476\u5b50\uff0c\u9ad8\u6a4b\u79c0\u884c\uff0c\u5742\u5009\u6d69\u4e00\uff0c\u6b66\u7530\u8302\u6a39\u3000\u30c8\u30e9\u30f3\u30b9\u30b8\u30a7\u30cb\u30c3\u30af\u30ab\u30a4\u30b3\u3092\u7528\u3044\u305f\u304c\u3093\u6297\u539f\u30bf\u30f3\u30d1\u30af\u306b\u3088\u308b\u304c\u3093\u30ef\u30af\u30c1\u30f3\u7642\u6cd5\u306e\u958b\u767a\u3000\u7b2c34\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u30002\/4-6\u3000(\u9ce5\u7fbd\u5e02)<\/li>\n
                       29. \u9ad8\u6a4b\u79c0\u884c\uff0c\u5742\u5009\u6d69\u4e00\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u764c\u95a2\u9023\u7dda\u7dad\u82bd\u7d30\u80de\u306e\u514d\u75ab\u5b66\u7684\u5f79\u5272\u3000\u7b2c34\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u30002\/4-6\u3000(\u9ce5\u7fbd\u5e02)<\/li>\n
                       30. \u5742\u5009\u6d69\u4e00\u3000\u982d\u9838\u90e8\u764c\u60a3\u8005\u672b\u68a2\u8840\u306e\u5358\u7403\u30b5\u30d6\u30bb\u30c3\u30c8\u306e\u5909\u5316\u3000\u7b2c13\u56de\u65e5\u672c\u514d\u75ab\u6cbb\u7642\u5b66\u7814\u7a76\u4f1a\u30002\/27\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                       31. \u8429\u539f\u3000\u5f18\u5e78\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u539f\u767a\u306ecellular fibrous histiocytoma \u306e\u4e00\u4f8b\u3000\u7b2c28\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/3-4\u3000(\u5927\u962a\u5e02)<\/li>\n<\/ol>\n

                            <\/p>\n

                           \u5b66\u4f1a\u767a\u8868\uff082014\u5e74\u5ea6\uff09<\/h1>\n

                           \n
                           1. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u658e\u85e4\u6df3\u4e00\u3001\u767d\u4e95\u514b\u5e78\u3001\u5927\u91ce\u9054\u4e5f\u3001\u4e2d\u91ce\u9686\u53f2\u3000\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u60aa\u6027\u9ed2\u8272\u816b\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c115\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/14-17\uff08\u798f\u5ca1\u5e02\uff09<\/li>\n
                           2. \u5742\u5009\u6d69\u4e00\u3001\u9ad8\u6a4b\u79c0\u884c\u3001\u89e3\u826f\u606d\u4e00\u3001\u8c4a\u7530\u5b9f\u3001\u5c0f\u5c71\u5fb9\u4e5f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u53e3\u8154\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308bautophagy\u95a2\u9023\u5206\u5b50\u306e\u767a\u73fe\u3068\u816b\u760d\u6d78\u6f64\u514d\u75ab\u7d30\u80de\u3068\u306e\u95a2\u4fc2\u3000\u7b2c115\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/14-17\uff08\u798f\u5ca1\u5e02\uff09<\/li>\n
                           3. \u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u6975\u7d30\u5f84\u306e\u8edf\u6027\u6c17\u7ba1\u652f\u93e1\u3092\u7528\u3044\u305f\u4e73\u5150\u6c17\u7ba1\u652f\u7570\u7269\u6458\u51fa2\u75c7\u4f8b\u3000\u7b2c9\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/6-7\uff08\u6d5c\u677e\u5e02\uff09<\/li>\n
                           4. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u65b0\u3057\u3044\u9f3b\u51fa\u8840\u306e\u6b62\u8840\u6cd5Over Gauze Coagulation\uff08OGC\uff09\u2015\u4f5c\u52d5\u539f\u7406\u306b\u57fa\u3065\u304f\u6b62\u8840\u6cd5\u306e\u5de5\u592b\u2015\u3000\u7b2c115\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/14-17\uff08\u798f\u5ca1\u5e02\uff09<\/li>\n
                           5. \u5b89\u5ca1\u7fa9\u4eba\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5c0f\u5150\u5589\u982d\u7570\u72693\u75c7\u4f8b\u306e\u7d4c\u9a13\u3000\u7b2c9\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/6-7\uff08\u6d5c\u677e\u5e02\uff09<\/li>\n
                           6. \u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u6b63\u4e2d\u9838\u56a2\u80de\u3068\u601d\u308f\u308c\u305f\u524d\u9838\u90e8\u7570\u6240\u6027\u7532\u72b6\u817a\u306e\u4e00\u4f8b\u3000\u7b2c9\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/6-7\uff08\u6d5c\u677e\u5e02\uff09<\/li>\n
                           7. \u5742\u5009\u6d69\u4e00\uff0c\u9ad8\u6a4b\u79c0\u884c\u3001\u89e3\u826f\u606d\u4e00\u3001\u8c4a\u7530\u5b9f\u3001\u5c0f\u5c71\u5fb9\u4e5f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u820c\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308bautophagy \u95a2\u9023\u5206\u5b50\u306e\u767a\u73fe\u3068\u816b\u760d\u514d\u75ab\u539f\u6027\u3068\u306e\u95a2\u4fc2\u3000\u7b2c38\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/12-13\u3000(\u6771\u4eac\u90fd)<\/li>\n
                           8. \u9ad8\u5b89\u5e78\u5f18\uff0c\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3001\u658e\u85e4\u6df3\u4e00\u3001\u767d\u4e95\u514b\u5e78\u3001\u5927\u91ce\u9054\u4e5f\u3001\u4e2d\u91ce\u9686\u53f2\u3000\u3000\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u9818\u57df\u817a\u69d8\u56a2\u80de\u764c\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306e\u77ed\u671f\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c38\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/12-13\u3000(\u6771\u4eac\u90fd)<\/li>\n
                           9. \u65b0\u570b\u6442\u3001\u9234\u6728\u653f\u7f8e\u3001\u5ddd\u7530\u502b\u4e4b\u3001\u5ca1\u7530\u9686\u5e73\u3000\u53e3\u84cb\u6241\u6843\u8ee2\u79fb\u3092\u6765\u3057\u305f\u539f\u767a\u6027\u80ba\u764c\u306e1 \u4f8b\u3000\u2014 \u53e3\u84cb\u6241\u6843\u8ee2\u79fb\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\u306b\u3064\u3044\u3066\u306e\u8003\u5bdf\u2014\u3000\u7b2c38\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/12-13\u3000(\u6771\u4eac\u90fd)<\/li>\n
                           10. \u77e2\u5cf6\u7f8e\u9999\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5e73\u6238\u7d14\u5b50\u3001\u8c4a\u7530\u5b9f\u3001\u5bae\ufa11\u771e\u7948\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305fRosai-Dorfman disease \u306e1\u4f8b\u3000\u7b2c76\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/26-27\uff08\u76db\u5ca1\u5e02\uff09<\/li>\n
                           11. \u5bae\ufa11\u771e\u7948\u3001\u77e2\u5cf6\u7f8e\u9999\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u52d5\u9759\u8108\u763b\u306e\u7834\u88c2\u306b\u3088\u308b\u9838\u90e8\u816b\u8139\u3068\u6c17\u7ba1\u72ed\u7a84\u306e1\u75c7\u4f8b\u3000\u7b2c76\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/26-27\uff08\u76db\u5ca1\u5e02\uff09<\/li>\n
                           12. \u5fa1\u4efb\u4e00\u5149\u3001\u5de5\u85e4\u6bc5\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9ad8\u9f62\u8005\u306eLemierre\u75c7\u5019\u7fa4\u306e1\u4f8b\u3000\u7b2c76\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/26-27\uff08\u76db\u5ca1\u5e02\uff09<\/li>\n
                           13. \u8c4a\u7530\u5b9f\u3001\u77e2\u5cf6\u7f8e\u9999\u3001\u5bae\ufa11\u771e\u7948\u3001\u8fd1\u677e\u4e00\u6717\u3000\u6c17\u7ba1\u5207\u958b\u5b54\u3068\u80c3\u763b\u90e8\u306b\u8ee2\u79fb\u3092\u304d\u305f\u3057\u305f\u820c\u764c\u306e\uff11\u4f8b\u3000\u7b2c76\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30006\/26-27\uff08\u76db\u5ca1\u5e02\uff09<\/li>\n
                           14. \u77e2\u5cf6\u7f8e\u9999\u3001\u5bae\u5d0e\u771e\u7948\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5e73\u6238\u7d14\u5b50\u3000\u8a3a\u65ad\u306b\u96e3\u6e0b\u3057\u305fRosai-Dorfman\u75c5\u3000\u7b2c107\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/29(\u524d\u6a4b\u5e02)<\/li>\n
                           15. \u5bae\u5d0e\u771e\u7948\uff08\u6850\u751f\u539a\u751f\uff09\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u52d5\u9759\u8108\u763b\u306e\u7834\u88c2\u306b\u3088\u308b\u9838\u90e8\u816b\u8139\u3068\u6c17\u9053\u72ed\u7a84\u306e\u4e00\u4f8b\u3000\u7b2c107\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/29(\u524d\u6a4b\u5e02)<\/li>\n
                           16. \u5b89\u5ca1\u7fa9\u4eba\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5c0f\u5150\u54bd\u982d\u7570\u72693\u75c7\u4f8b\u306e\u7d4c\u9a13\u3000\u7b2c107\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/29(\u524d\u6a4b\u5e02)<\/li>\n
                           17. \u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u6975\u7d30\u5f84\u306e\u8edf\u6027\u6c17\u7ba1\u652f\u93e1\u3092\u7528\u3044\u305f\u4e73\u5150\u6c17\u7ba1\u652f\u7570\u7269\u6458\u51fa2\u75c7\u4f8b\u3000\u7b2c107\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/29(\u524d\u6a4b\u5e02)<\/li>\n
                           18. \u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u6a5f\u80fd\u6027\u96e3\u8074\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c107\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/29(\u524d\u6a4b\u5e02)<\/li>\n
                           19. Yukihiro Takayasu, Masato Shino, Minoru Toyoda, Katsumasa Takahashi, Kazuaki Chikamatsu, Jun-ichi Saitoh, Katsuyuki Shirai, Tatsuya Ohno, Takashi Nakano \u3000Results Of Carbon Ion Radiotherapy For Mucosal Malignant Melanoma Of The Head And Neck IFHNOS 5^{th<\/sup>\u00a0World Congress And AHNS Annual Mtg. NY, USA July 26-30, 2014<\/li>\n}
                           20. Koichi Sakakura, Minoru Toyoda, Tetsunari Oyama, Kazuaaki Chikamatsu Immunological significance of autophagy components accumulated in oral squamous cell carcinoma IFHNOS 5^{th<\/sup>\u00a0World Congress And AHNS Annual Mtg. NY, USA July 26-30, 2014<\/li>\n}
                           21. Hideyuki Takahashi, Koichi Sakakura, Kazuaki Chikamatsu\u3000Immunological significance of cancer-associated fibroblasts in head and neck squamous cell carcinoma IFHNOS 5^{th<\/sup>\u00a0World Congress And AHNS Annual Mtg. NY, USA July 26-30, 2014<\/li>\n}
                           22. Yuki Yokobori, Minoru Toyoda, Koichi Sakakura, K Kaira, Kazuaki Chikamatsu Biological significance of 18F-FDG PET in early stage oral squamous cell carcinoma IFHNOS 5^{th<\/sup>\u00a0World Congress And AHNS Annual Mtg. NY, USA July 26-30, 2014<\/li>\n}
                           23. \u5ca1\u672c\u5f69\u5b50\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5e73\u6238\u7d14\u5b50\u3000\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u6c17\u7ba1\u652f\u80ba\u5fc3\u7b4b\u75c7\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c\u305f\u30b9\u30a8\u30d2\u30ed\u30bf\u30b1\u306b\u3088\u308b\u4e21\u5074\u526f\u9f3b\u8154\u771f\u83cc\u75c7\u306e\uff11\u4f8b\u3000\u7b2c53\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/25-27\uff08\u5927\u962a\u5e02\uff09<\/li>\n
                           24. \u9ad8\u6a4b\u514b\u660c\u3001\u767b\u5742\u96c5\u5f66\u3001\u65b0\u4e95\u57fa\u5c55\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7d4c\u8776\u5f62\u9aa8\u6d1e\u624b\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u958b\u653e\u3057\u305f\u5de6\u5916\u8ee2\u795e\u7d4c\u9ebb\u75fa\u3092\u4f34\u3046\u9310\u4f53\u5c16\u90e8\u30b3\u30ec\u30b9\u30c6\u30ea\u30f3\u8089\u82bd\u816b\u306e1\u4f8b\u3000\u7b2c53\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/25-27\uff08\u5927\u962a\u5e02\uff09<\/li>\n
                           25. Hideyuki Takahashi, Koichi Sakakura, Kazuaki Chikamatsu Immunosuppressive role of cancer-associated fibroblasts in head and neck squamous cell carcinoma\u3000The 73rd Annual Meeting of the Japanese Cancer Association\u300025-27\uff08Yokohama\uff09<\/li>\n
                           26. \u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8853\u5f8c\u958b\u653e\u4e73\u7a81\u8154\u969c\u5bb3\u306b\u5bfe\u3057\u3066\u5916\u8033\u9053\u5f8c\u58c1\u518d\u5efa\u624b\u8853\u3092\u884c\u3063\u305f\u75c7\u4f8b\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\u3000\u7b2c24\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300010\/15-18\uff08\u65b0\u6f5f\u5e02\uff09<\/li>\n
                           27. \u9ad8\u6a4b\u514b\u660c\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7d30\u83cc\u907a\u4f1d\u5b50\u691c\u67fb\u306b\u3088\u308b\u8033\u8853\u5f8c\u611f\u67d3\u306e\u8fc5\u901f\u540c\u5b9a\u3000\u7b2c24\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300010\/15-18\uff08\u65b0\u6f5f\u5e02\uff09<\/li>\n
                           28. \u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u7fa4\u99ac\u770c\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u8074\u899a\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u73fe\u6cc1\u3000\u7b2c59\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300011\/27-28\uff08\u4e0b\u95a2\u5e02\uff09<\/li>\n
                           29. \u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u6c34\u8c37\u6e05\u9686\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u30c7\u30b8\u30bf\u30eb\u7121\u7dda\u65b9\u5f0f\u88dc\u8074\u63f4\u52a9\u30b7\u30b9\u30c6\u30e0\u306e\u4f7f\u7528\u7d4c\u9a13\u3000\u7b2c59\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300011\/27-28\uff08\u4e0b\u95a2\u5e02\uff09<\/li>\n
                           30. \u6751\u7530\u8003\u5553\u3000\u3000\u5185\u8996\u93e1\u4e0b\u5351\u52a3\u8edf\u9aa8\u5185\u8ee2\u8853\u3000\u30d3\u30c7\u30aa\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000\u7b2c66\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300011\/13-14\uff08\u9ad8\u77e5\u5e02\uff09<\/li>\n
                           31. \u7d2b\u91ce\u6b63\u4eba\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5\uff09\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3000\u7b2c66\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300011\/13-14\uff08\u9ad8\u77e5\u5e02\uff09<\/li>\n
                           32. \u5742\u5009\u6d69\u4e00\u3001\u5343\u4ee3\u7530\u670b\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3001\u7530\u6fa4\u660c\u4e4b\u3001\u5c0f\u83c5\u5948\u6d25\u5b50\u3001\u9ad8\u57ce\u58ee\u767b\u3001\u9234\u6728\u6df3\u3001\u548c\u7530\u76f4\u6a39\u3001\u767d\u5009\u8ce2\u4e8c\u3001\u68ee\u7530\u6e80\u7406\u5b50\u3001\u91d1\u4e95\u96c5\u4ee3\u3001\u91d1\u4e95\u53cb\u91cc\u3000\u5f53\u9662\u306b\u304a\u3051\u308b\u591a\u8077\u7a2e\u9023\u643a\u56a5\u4e0b\u56de\u8a3a\u306e\u73fe\u6cc1\u3000\u7b2c108\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300011\/30\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                           33. \u4e95\u7530\u7fd4\u592a\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u764c\u306b\u5bfe\u3059\u308bCetuximab \u306e\u4f7f\u7528\u7d4c\u9a13\u3068\u5b89\u5168\u6027\u306e\u691c\u8a0e\u3000\u7b2c25\u56de\u65e5\u672c\u982d\u9838\u90e8\u5916\u79d1\u5b66\u4f1a\u30001\/29-30\uff08\u5927\u962a\u5e9c\uff09<\/li>\n
                           34. \u65b0\u570b\u6442\u3000\u7dcf\u9838\u52d5\u8108\u7d50\u7d2e\u3057\u6551\u547d\u3057\u3048\u305f\u4e0b\u54bd\u982d\u764c\u306e1 \u4f8b\u3000\u7b2c25\u56de\u65e5\u672c\u982d\u9838\u90e8\u5916\u79d1\u5b66\u4f1a\u30001\/29-30\uff08\u5927\u962a\u5e9c\uff09<\/li>\n<\/ol>\n

                                <\/p>\n

                               \u5b66\u4f1a\u767a\u8868\uff082013\u5e74\u5ea6\uff09<\/h1>\n

                               \n
                               1. \u7d2b\u91ce\u6b63\u4eba\u3001\u6a2a\u5800\u6709\u7d00\u3001\u6751\u7530\u8003\u5553\u3001\u5cf6\u7530\u54f2\u660e\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717^{\u3000<\/sup>\u6cbb\u7642\u306b\u96e3\u6e0b\u3057\u3066\u3044\u308b\u4e21\u5074\u58f0\u5e2f\u5916\u8ee2\u969c\u5bb3\u306e1\u4f8b\u3000\u7b2c34\u56de\u6771\u65e5\u672c\u97f3\u58f0\u5916\u79d1\u7814\u7a76\u4f1a\u30014\/10(\u6771\u4eac\u90fd)<\/li>\n}
                               2. Koichi Sakakura, Takaaki Murata, Minoru Toyoda, Yuki Yokobori, Kazuaki Chikamatsu\u3000Therapeutic potentials of histone deacetylase inhibitors for cancer stem cell-like cell phenotype in squamous cell carcinoma of the head and neck\u3000AACR Washington, DC April 6-10, 2013<\/li>\n
                               3. Minoru Toyoda, Koichi Sakakura, Yuki Yokobori, Kazuaki Chikamatsu\u3000Biological markers as predictors of clinical outcome in adenoid cystic carcinoma of the head and neck\u3000COSM Spring Meeting , Orlando USA, April 10-14, 2013<\/li>\n
                               4. Koichi Sakakura, Takaaki Murata, Kazuaki Chikamatsu Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck\u3000COSM Spring Meeting , Orlando USA, April 10-14, 2013<\/li>\n
                               5. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u6589\u85e4\u6df3\u4e00\u3001\u767d\u4e95\u514b\u5e78\u3001\u5927\u91ce\u9054\u4e5f\u3001\u4e2d\u91ce\u9686\u53f2\u3000\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u975e\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c114\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\u670815-18\u65e5\uff08\u672d\u5e4c\u5e02\uff09<\/li>\n
                               6. \u8c4a\u7530\u5b9f\u3001\u5742\u5009\u6d69\u4e00\u3001\u89e3\u826f\u606d\u4e00\u3001\u6a2a\u5800\u6709\u7d00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u817a\u69d8\u56a2\u80de\u764c\u306e\u65b0\u3057\u3044\u4e88\u5f8c\u306e\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e\u3000\u7b2c114\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\u670815-18\u65e5\uff08\u672d\u5e4c\u5e02\uff09<\/li>\n
                               7. \u8c4a\u7530\u5b9f\u3001\u5742\u5009\u6d69\u4e00\u3001\u89e3\u826f\u606d\u4e00\u3001\u6a2a\u5800\u6709\u7d00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u817a\u69d8\u56a2\u80de\u764c\u306e\u65b0\u3057\u3044\u4e88\u5f8c\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e\u3000\u7b2c37\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\u670813-14\u65e5\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                               8. \u6a2a\u5800\u6709\u7d00\u3001\u8c4a\u7530\u5b9f\u3001\u5742\u5009\u6d69\u4e00\u3001\u89e3\u826f\u606d\u4e00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u53e3\u8154\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308bFDG-PET max SUV\u5024\u306eimaging biomarker \u3068\u3057\u3066\u306e\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u3000\u7b2c37\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\u670813-14\u65e5\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                               9. \u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u6a2a\u5800\u6709\u7d00\uff0c\u5bcc\u6fa4\u7d18\u6075\uff0c\u5bae\u5d0e\u771e\u7948\uff0c\u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u7fa4\u99ac\u770c\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u8074\u899a\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u300crefer \u5150\u300d\u306b\u5bfe\u3059\u308b\u65e9\u671f\u7642\u80b2\u4f53\u5236\u3068\u73fe\u6cc1\u3000\u7b2c8\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\u670820-21\u65e5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               10. \u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u5728\u65e5\u5916\u56fd\u4eba\u306e\u96e3\u8074\u5150\u652f\u63f4\u306e\u5b9f\u614b\u3000\u7b2c8\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\u670820-21\u65e5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               11. \u7267\u53e3\u8cb4\u54c9\uff0c\u6751\u7530\u8003\u5553\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u6a2a\u5c3e\u8061\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u4f4e\u5e74\u9f62\u5150\u4eba\u5de5\u5185\u8033\u624b\u8853\u306e\u8853\u5f8c\u9732\u51fa\u306b\u5bfe\u3059\u308b\u76ae\u5f01\u3092\u7528\u3044\u305f\u88ab\u8986\u8853\uff5e\u88ab\u8986\u8853\u5f0f\u306e\u691c\u8a0e\u3068\u4eba\u5de5\u5185\u8033\u5165\u308c\u66ff\u3048\u306e\u662f\u975e\uff5e\u3000\u7b2c8\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\u670820-21\u65e5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               12. \u7d2b\u91ce\u6b63\u4eba\uff0c\u5b89\u5ca1\u7fa9\u4eba\uff0c\u8c4a\u7530\u5b9f\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6a2a\u5800\u6709\u7d00\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u4e73\u5e7c\u5150\u306e\u6c17\u7ba1\u958b\u7a93\u8853\uff08\u30c8\u30e9\u30d5\u6cd5\u3000\u7b2c8\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\u670820-21\u65e5\uff08\u524d\u6a4b\u5e02\uff09\uff09<\/li>\n
                               13. \u4e2d\u5cf6\u606d\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u5929\u91ce\u535a\u96c4\uff0c\u6fa4\u6d66\u6cd5\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000Cockayne \u75c7\u5019\u7fa4\u306e\u4e00\u4f8b\u3000\u7b2c8\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\u670820-21\u65e5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               14. \u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5929\u91ce\u535a\u96c4\u3001\u6fa4\u6d66\u6cd5\u5b50\u3000Cockayne\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b\u3000\u3000\u7b2c104\u56de\u65e5\u8033\u9f3b\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/30\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               15. \u6a2a\u5800\u6709\u7d00\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8d85\u9078\u629e\u7684\u52d5\u6ce8\u5316\u5b66\u4f75\u7528\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u8457\u52b9\u3057\u305f\u4e0a\u984e\u6d1e\u7b4b\u4e0a\u76ae\u764c\u306e1\u4f8b\u3000\u7b2c104\u56de\u65e5\u8033\u9f3b\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/30\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               16. \u5b89\u5ca1\u7fa9\u4eba\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u591a\u7530\u7d18\u6075\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9f3b\u51fa\u8840\u306e\u8840\u7ba1\u75c5\u614b\u306b\u57fa\u3065\u304f\u65b0\u3057\u3044\u7c21\u4fbf\u306a\u6b62\u8840\u6cd5\u2015Over Gauze Coagulation(OGC)\u306e\u9069\u5fdc\u3068\u624b\u6280\u2015\u3000\u7b2c104\u56de\u65e5\u8033\u9f3b\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/30\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               17. \u6a2a\u5800\u6709\u7d00\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8d85\u9078\u629e\u7684\u52d5\u6ce8\u5316\u5b66\u7642\u6cd5\u4f75\u7528\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u8457\u52b9\u3057\u305f\u4e0a\u984e\u6d1e\u7b4b\u4e0a\u76ae\u764c\u306e1\u4f8b\u3000\u7b2c75\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30007\/11-12\uff08\u795e\u6238\u5e02\uff09<\/li>\n
                               18. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u6a2a\u5800\u6709\u7d00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9f3b\u51fa\u8840\u6b62\u8840\u6cd5\u306e\u4e00\u5de5\u592b\u2015Over Gauze Coagulation(OGC)\u2015\u3000\u7b2c75\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30007\/11-12\uff08\u795e\u6238\u5e02\uff09<\/li>\n
                               19. \u8c4a\u7530\u5b9f\u3001\u6a2a\u5800\u6709\u7d00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8033\u4e0b\u817a\u306b\u751f\u3058\u305f\u885d\u7a81\u816b\u760d\u306e1\u4f8b\u3000\u7b2c75\u56de\u8033\u9f3b\u54bd\u5589\u79d1\u81e8\u5e8a\u5b66\u4f1a\u30007\/11-12\uff08\u795e\u6238\u5e02\uff09<\/li>\n
                               20. \u5b89\u5ca1\u3000\u7fa9\u4eba\uff0c\u9ad8\u6a4b\u3000\u514b\u660c\uff0c\u591a\u7530\u3000\u7d18\u6075\uff0c\u938c\u7530\u3000\u82f1\u7537\uff0c\u8fd1\u677e\u3000\u4e00\u6717\u3000\u9f3b\u51fa\u8840\u306e\u8840\u7ba1\u75c5\u614b\u306b\u57fa\u3065\u304f\u65b0\u3057\u3044\u7c21\u4fbf\u306a\u6b62\u8840\u6cd5 \u2015Over Gauze Coagulation\uff08OGC\uff09\u306e\u9069\u5fdc\u3068\u624b\u6280\u2015\u3000\u7b2c52\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/26-28(\u798f\u4e95\u5e02)<\/li>\n
                               21. \u591a\u7530\u3000\u7d18\u6075\uff0c\u9ad8\u6a4b\u3000\u514b\u660c\uff0c\u8fd1\u677e\u3000\u4e00\u6717\u3000\u4e0a\u984e\u6d1e\u539f\u767a\u306e\u80ba\u5916\u6df7\u5408\u578b\u5c0f\u7d30\u80de\u764c\u306e\u4e00\u4f8b\u3000\u7b2c52\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/26-28(\u798f\u4e95\u5e02)<\/li>\n
                               22. \u9ad8\u6a4b\u3000\u514b\u660c\uff0c\u767b\u5742\u3000\u96c5\u5f66\uff0c\u8fd1\u677e\u3000\u4e00\u6717\u3000\u7d4c\u9f3b\u4e2d\u9694\u6cd5\u306b\u3088\u308b\u5185\u8996\u93e1\u4e0b\u5782\u4f53\u624b\u8853\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c52\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/26-28(\u798f\u4e95\u5e02)<\/li>\n
                               23. \u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u6885\u672c\u548c\u6b63\uff0c\u4e38\u5c71\u61b2\u4e00\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u4f4e\u51fa\u751f\u4f53\u91cd\u5150\u306e\u8074\u899a\u969c\u5bb3\u306e\u4e88\u5f8c\u3000\u7b2c58\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/24-25(\u677e\u672c\u5e02)<\/li>\n
                               24. \u7be0\u539f\u60a0\u5b50\uff0c\u5c0f\u539f\u900f\uff0c\u6885\u672c\u548c\u6b63\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u88dc\u8074\u5668\u8cfc\u5165\u3057\u305f\u8efd\u4e2d\u7b49\u5ea6\u96e3\u8074\u5150\u306b\u95a2\u3059\u308b\u691c\u8a0e\u3000\u7b2c58\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/24-25(\u677e\u672c\u5e02)<\/li>\n
                               25. \u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u96e3\u8074\u907a\u4f1d\u5b50\u8a3a\u65ad\u306e\u73fe\u72b6\uff5e\u8a3a\u65ad\u7d50\u679c\u306e\u614e\u91cd\u306a\u89e3\u91c8\u3092\u8981\u3057\u305f\uff11\u75c7\u4f8b\uff5e\u3000\u7b2c58\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/24-25(\u677e\u672c\u5e02)<\/li>\n
                               26. \u5c0f\u539f\u900f\uff0c\u6885\u672c\u548c\u6b63\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u8a8d\u77e5\u6a5f\u80fd\u306e\u4f4e\u4e0b\u3057\u305f\u4eba\u5de5\u5185\u8033\u88c5\u7528\u9ad8\u9f62\u8005\u3078\u306e\u5bfe\u5fdc\u3000\u7b2c58\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/24-25(\u677e\u672c\u5e02)<\/li>\n
                               27. \u4e2d\u5cf6\u606d\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u5c0f\u539f\u900f\uff0c\u7be0\u539f\u60a0\u5b50\uff0c\u6885\u672c\u548c\u6b63\uff0c\u6fa4\u7530\u88d5\u4e5f\uff0c\u5c0f\u6797\u83ef\u8863\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u6a5f\u80fd\u6027\u96e3\u8074\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c58\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/24-25(\u677e\u672c\u5e02)<\/li>\n
                               28. \u5cf6\u7530\u54f2\u660e\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS\uff09\u65bd\u884c\u5f8c\u306b\u518d\u624b\u8853\u3092\u8981\u3057\u305f\u4e00\u75c7\u4f8b\u3000\u7b2c65\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300010\/31-11\/1\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                               29. \u5b89\u5ca1\u7fa9\u4eba\u3001\u5b88\u672c\u502b\u5b50\u3001\u76ca\u7530\u614e\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5c0f\u5150\u58f0\u9580\u5f8c\u90e8\u5f62\u6210\u8853\u306e\u5de5\u592b\u3000\u7b2c65\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300010\/31-11\/1\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                               30. \u9ad8\u6a4b\u514b\u660c\uff0c\u7d2b\u91ce\u6b63\u4eba\uff0c\u65b0\u570b\u6442\uff0c\u5ca1\u5bae\u667a\u53f2\uff0c\u9ad8\u5b89\u5e78\u5f18\uff0c\u8fd1\u677e\u4e00\u6717\u3000\u553e\u6db2\u4e2d\u30d8\u30eb\u30da\u30b9\u30a6\u30a4\u30eb\u30b9DNA \u6e2c\u5b9a\u306b\u3088\u308b\u30e1\u30cb\u30a8\u30fc\u30eb\u75c5\u767a\u4f5c\u671f\u306e\u75b2\u52b4\u5ea6\u6e2c\u5b9a\u3000\u7b2c72\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/13-15\uff08\u5927\u962a\u5e02\uff09<\/li>\n
                               31. \u591a\u8cc0\u8c37\u6cf0\u5f18\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u5c0f\u539f \u900f\u3001\u7be0\u539f\u60a0\u5b50\u3000\u7fa4\u99ac\u770c\u306b\u304a\u3051\u308b\u8efd\u30fb\u4e2d\u7b49\u5ea6\u96e3\u8074\u5150\u88dc\u8074\u5668\u8cfc\u5165\u652f\u63f4\u4e8b\u696d\u306e\u5b9f\u7e3e\u3000\u7b2c105\u56de\u65e5\u8033\u9f3b\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               32. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u96fb\u5b50\u5185\u8996\u93e1\u3067\u8a3a\u308b\u8033\u9f3b\u54bd\u5589\u79d1\u8a3a\u7642\u305d\u306e\uff11\uff0d\u54bd\u982d\u9b5a\u9aa8\u7570\u7269\uff0d\u3000\u7b2c105\u56de\u65e5\u8033\u9f3b\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                               33. \u9234\u6728\u653f\u7f8e\u3001\u5ddd\u7530\u502b\u4e4b\u3001\u65b0\u570b\u6442\u3000\u53e3\u8154\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u984e\u4e0b\u817a\u8ee2\u79fb\u30fb\u984e\u4e0b\u817a\u6d78\u6f64\u306e\u691c\u8a0e\u3000\u7b2c24\u56de\u65e5\u672c\u982d\u9838\u90e8\u5916\u79d1\u5b66\u4f1a\u30001\/30-31\uff08\u9ad8\u677e\u5e02\uff09<\/li>\n
                               34. \u9ad8\u6a4b\u79c0\u884c\u3001\u5742\u5009\u6d69\u4e00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u982d\u981a\u7ff3\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u764c\u95a2\u9023\u7dda\u7dad\u82bd\u7d30\u80de\u306e\u514d\u75ab\u6291\u5236\u6a5f\u69cb\u3078\u306e\u95a2\u4e0e\u3000\u7b2c32\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u30002\/6-8\uff08\u5fb3\u5cf6\uff09<\/li>\n
                               35. \u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u5343\u4ee3\u7530\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5\uff09\u306b\u304a\u3051\u308b\u30c8\u30e9\u30d5\u5f62\u6210\u306e\u5de5\u592b\u3000\u7b2c26\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/6-7\uff08\u90a3\u8987\u5e02\uff09<\/li>\n
                               36. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000Over Gauze Coagulation (OGC) \uff0d\u4f5c\u52d5\u539f\u7406\u3068\u8853\u5f8c\u7d4c\u904e\uff0d\u3000\u7b2c106\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30003\/9\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n<\/ol>\n

                                    <\/p>\n

                                   \u5b66\u4f1a\u767a\u8868\uff082012\u5e74\u5ea6\uff09<\/h1>\n

                                   \n
                                   1. \u5cf6\u7530\u54f2\u660e\u3000\u4e16\u754c\u521d\u306e\u4f4e\u4fb5\u8972\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS)\u300f\u3000\u7b2c33\u56de\u6771\u65e5\u672c\u97f3\u58f0\u5916\u79d1\u7814\u7a76\u4f1a\u30014\/7(\u6771\u4eac\u90fd)<\/li>\n
                                   2. \u98ef\u7530\u82f1\u57fa\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u5f8c\u30ab\u30cb\u30e5\u30fc\u30ec\u30c8\u30e9\u30d6\u30eb\u306b\u5bfe\u5fdc\u3092\u8981\u3057\u305f2\u4f8b\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   3. \u52a0\u5bb6\u58c1\u7f8e\u6a39\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e0a\u984e\u6d1e\u539f\u767aSmall cell neuroendcrine carcinoma\u306e1\u4f8b\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   4. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\uff08\u7fa4\u5927\uff09\u3001\u767d\u4e95\u514b\u5e78\u3001\u9f4a\u85e4\u6df3\u4e00\u3001\u5927\u91ce\u9054\u4e5f\u3001\u4e2d\u91ce\u9686\u53f2\uff08\u540c\u30fb\u653e\u5c04\u7dda\u79d1\uff09\u3000\u7fa4\u99ac\u5927\u5b66\u8033\u9f3b\u54bd\u5589\u79d1\u306b\u304a\u3051\u308b \u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306e\u7d4c\u904e\u5831\u544a \uff5e\u60aa\u6027\u9ed2\u8272\u816b\u75c7\u4f8b\u4ee5\u5916\u3092\u4e2d\u5fc3\u306b\uff5e\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   5. \u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u96e3\u8074\u7591\u3044\u3067\u5f53\u79d1\u3092\u53d7\u8a3a\u3057\u305f\u5e83\u6c4e\u6027\u767a\u9054\u969c\u5bb3\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   6. \u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8133\u816b\u760d\u6458\u51fa\u5f8c\u306b\u8074\u529b\u304c\u4f4e\u4e0b\u3057\u305f\u8133\u8868\u30d8\u30e2\u30b8\u30c7\u30ea\u30f3\u6c88\u7740\u75c7\u306e1\u4f8b\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   7. \u5cf6\u7530\u54f2\u660e\u3000\u52a0\u5bb6\u58c1\u7f8e\u6a39\u5b50\u3000\u938c\u7530\u82f1\u7537\u3000\u53e4\u5c4b\u4fe1\u5f66\u3000\u8fd1\u677e\u4e00\u6717\u3000NBI\u53ca\u3073Crystal violet\u67d3\u8272\u3092\u4f75\u7528\u3057\u305fcontact endoscopy\u306b\u3088\u308b\u820c\u7c98\u819c\u306e\u89b3\u5bdf\u3000\u7b2c100\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30004\/8\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   8. Masato Shino, Takaaki Murata, Yoshihito Yasuoka, Kazuaki Chikamatsu\u3000Improvement of tracheal flap method for laryngotracheal separation\u3000 American Laryngological Association (ALA)\u3000April 18-22, San Diego, CA, USA<\/li>\n
                                   9. Takaaki Murata Clinical Evaluation of Safety and Efficacy of Endoscopic-Assisted Arytenoid Adduction Surgery Combined Otolaryngology Spring Meetings, April 18-22, Manchester Grand Hyatt, San Diego, California, USA<\/li>\n
                                   10. \u9ad8\u6a4b\u514b\u660c\u3001\u677e\u5c71\u654f\u4e4b\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u52a0\u5bb6\u58c1\u7f8e\u6a39\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u5cf6\u7530\u54f2\u660e\u3001\u98ef\u7530\u82f1\u57fa\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u8c4a\u7530\u5b9f\u3001\u5bae\u4e0b\u5143\u660e\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308bTPF\u5316\u5b66\u7642\u6cd5\u306b\u3088\u308b\u597d\u4e2d\u7403\u73fe\u75c7\u306b\u3064\u3044\u3066\u306e\u8003\u5bdf\u3000\u7b2c113\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/10-12\uff08\u65b0\u6f5f\u5e02\uff09<\/li>\n
                                   11. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9f3b\u51fa\u8840\u6b62\u8840\u6cd5\u306e\u4e00\u5de5\u592b-Over Gauze Coagulation (OGC)-\u3000 \u7b2c113\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/10-12\uff08\u65b0\u6f5f\u5e02\uff09<\/li>\n
                                   12. \u5742\u5009\u6d69\u4e00\u3001\u8c4a\u7530\u5b9f\u3001\u5897\u5c71\u656c\u7950\u3001\u8fd1\u677e\u4e00\u6717\u3000\u982d\u9838\u90e8\u764c\u306b\u304a\u3051\u308bCD14+HLA-DR-\u5358\u7403\u7cfb\u30df\u30a8\u30ed\u30a4\u30c9\u7531\u6765\u30b5\u30d7\u30ec\u30c3\u30b5\u30fc\u7d30\u80de\u306b\u3088\u308b\u514d\u75ab\u6291\u5236\u52b9\u679c\u3000\u7b2c36\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/7-8\uff08\u677e\u6c5f\u5e02\uff09<\/li>\n
                                   13. \u52a0\u5bb6\u58c1\u7f8e\u6a39\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5742\u5009\u6d69\u4e00\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e0a\u984e\u6d1e\u539f\u767aCombined small cell carcinoma\u306e\uff11\u4f8b\u3000\u7b2c36\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/7-8\uff08\u677e\u6c5f\u5e02\uff09<\/li>\n
                                   14. \u4e94\u5473\u6681\u61b2\u3001\u6a2a\u5c3e\u8061\u3001\u795e\u6238\u667a\u5e78\u3001\u6cb3\u5185\u5948\u7a42\u5b50\u3001\u8fd1\u677e \u4e00\u6717\u3000\u4e2d\u54bd\u982d\u764c\u8853\u5f8c\u306b\u751f\u3058\u305f\u56a5\u4e0b\u30fb\u69cb\u97f3\u969c\u5bb3\u306bbulb-PLP\u3092\u7528\u3044\u3066\u56de\u5fa9\u3092\u5f97\u305f\uff11\u4f8b\u3000\u7b2c36\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30006\/7-8\uff08\u677e\u6c5f\u5e02\uff09<\/li>\n
                                   15. \u6751\u7530\u8003\u5553\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u967d\u5b50\u7dda\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305f\u5c0f\u5150\u8033\u4e0b\u817a\u7c98\u8868\u76ae\u764c\u306e\uff11\u75c7\u4f8b\u3000\u7b2c\uff17\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/21-22\uff08\u5ca1\u5c71\u5e02\uff09<\/li>\n
                                   16. \u9577\u4e95\u4eca\u65e5\u5b50\u3001\u690e\u539f\u9686\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000Pelizaeus-Merzbacher\u75c5\u306e\u8074\u529b\u7d4c\u904e\u3000\u7b2c\uff17\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/21-22\uff08\u5ca1\u5c71\u5e02\uff09<\/li>\n
                                   17. \u4e2d\u5cf6\u606d\u5b50\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u91cd\u8907\u763b\u7ba1\u3092\u7591\u3063\u305f\u4e0b\u54bd\u982d\u68a8\u72b6\u9665\u51f9\u763b\u306e\u4e00\u4f8b\u3068\u305d\u306e\u767a\u751f\u671f\u9650\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\u3000\u7b2c\uff17\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/21-22\uff08\u5ca1\u5c71\u5e02\uff09<\/li>\n
                                   18. \u5b89\u5ca1\u7fa9\u4eba\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u4e8c\u5bae\u6d0b\u3001\u98ef\u7530\u82f1\u57fa\u3001\u6751\u7530\u8003\u5553\u3001\u8fd1\u677e\u4e00\u6717\u3001\u6e21\u8fba\u7f8e\u7dd2\u3001\u8352\u5ddd\u6d69\u4e00\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5A\u30fbB\u30fbC-type\uff09\u306e\u8853\u5f0f\u3068\u624b\u8853\u306e\u30b3\u30c4\u3000\u7b2c\uff17\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/21-22\uff08\u5ca1\u5c71\u5e02\uff09<\/li>\n
                                   19. Koichi Sakakura, Minoru Toyoda, Katsumasa Takahashi, Takanori Yamamoto, Motohiro Moriyama, Keisuke Masuyama, Kazuaki Chikamatsu Immunosuppressive Impact on Head and Neck Cancer Patients by CD14+HLA-DR-Myeloid-Derived Suppressor Cells\u00a0 8^{th<\/sup>\u00a0International Conference on Head and neck Cancer July 21-25 Toronto, Canada<\/li>\n}
                                   20. \u9ad8\u5b89\u5e78\u5f18\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u5bae\u4e0b\u5143\u660e\u3001\u8fd1\u677e\u4e00\u6717\u3000\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u3066\u3044\u308b\u96e3\u6cbb\u6027\u982d\u4f4d\u3081\u307e\u3044\u306e1\u75c7\u4f8b\u3000\u7b2c101\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30007\/29(\u524d\u6a4b\u5e02)<\/li>\n
                                   21. \u661f\u91ce \u7adc\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u53e3\u8154\u5185\u7570\u6642\u6027\u591a\u91cd\u764c\u306e1\u75c7\u4f8b<\/li>\n
                                   22. \u8c4a\u7530 \u5b9f\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u5185\u591a\u767a\u764c\u306e1\u75c7\u4f8b\u3000\u7b2c101\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30007\/29(\u524d\u6a4b\u5e02)<\/li>\n
                                   23. \u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5ddd\u5cf6\u9686\u5f18\u3001\u767b\u5742\u96c5\u5f66\u3001\u9577\u5c90\u667a\u4ec1\u3001\u597d\u672c\u88d5\u5e73\u3000\u7d4c\u9f3b\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308b\u659c\u53f0\u90e8\u751f\u691c\u3000\u7b2c101\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30007\/29(\u524d\u6a4b\u5e02)<\/li>\n
                                   24. \u5742\u5009\u3000\u6d69\u4e00\u3001\u8fd1\u677e\u3000\u4e00\u6717\u3001\u771f\u7530\u3000\u6176\u5b50\u3000\u6025\u6027\u671f\u75c5\u9662\u306b\u304a\u3051\u308b\u6442\u98df\u30fb\u56a5\u4e0b\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u30b7\u30b9\u30c6\u30e0\u306e\u78ba\u7acb\u306b\u5411\u3051\u305f\u8a66\u307f\u3000\u7b2c101\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30007\/29(\u524d\u6a4b\u5e02)<\/li>\n
                                   25. \u5b89\u5ca1\u7fa9\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000COSM\u5b66\u4f1a\uff08San Diego)\u306b\u53c2\u52a0\u3057\u3066\u3000\u7b2c101\u56de\u3000\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30007\/29(\u524d\u6a4b\u5e02)<\/li>\n
                                   26. \u5742\u5009\u6d69\u4e00\u3001\u771f\u7530\u6075\u5b50\u3000\u6025\u6027\u671f\u75c5\u9662\u306b\u304a\u3051\u308b\u6442\u98df\u30fb\u56a5\u4e0b\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u73fe\u6cc1\u3068\u554f\u984c\u70b9\u3000\u7b2c17\uff6518\u56de\u65e5\u672c\u6442\u98df\u30fb\u56a5\u4e0b\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u5b66\u4f1a\u30008\/31-9\/1\uff08\u672d\u5e4c\u5e02\uff09<\/li>\n
                                   27. \u5cf6\u7530\u54f2\u660e\u3001\u661f\u91ce\u7adc\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5473\u899a\u969c\u5bb3\u60a3\u8005\u306b\u304a\u3051\u308b\u8840\u6e05\u4e9c\u925b\u5024\u306e\u5909\u52d5\u3068\u5473\u899a\u8a8d\u77e5\u95d8\u57df\u306e\u691c\u8a0e\u3000\u7b2c25\u56de\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/13-14\uff08\u718a\u672c\u5e02\uff09<\/li>\n
                                   28. \u661f\u91ce\u7adc\u3001\u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9aa8\u9ac4\u79fb\u690d\u5f8c\u6162\u6027GVHD\u60a3\u8005\u306b\u767a\u75c7\u3057\u305f\u53e3\u8154\u5185\u7570\u6642\u6027\u591a\u91cd\u764c\u306e1\u75c7\u4f8b\u3000\u7b2c25\u56de\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/13-14\uff08\u718a\u672c\u5e02\uff09<\/li>\n
                                   29. \u938c\u7530\u82f1\u7537\u3001\u5cf6\u7530\u54f2\u660e\u3001\u661f\u91ce\u7adc\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306e\u5473\u899a\u969c\u5bb3\u75c7\u4f8b\u3000\u7b2c25\u56de\u65e5\u672c\u53e3\u8154\u30fb\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/13-14\uff08\u718a\u672c\u5e02\uff09<\/li>\n
                                   30. \u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000Pott\u2019s puffy tumor\u3092\u6765\u305f\u3057\u305f\u6210\u4eba\u6025\u6027\u526f\u9f3b\u8154\u708e\u306e1\u4f8b\u3000\u7b2c51\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/27-29\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                   31. \u938c\u7530\u82f1\u7537\u3001\u5cf6\u7530\u54f2\u660e\u3001\u8fd1\u677e\u4e00\u6717\u3000\u611f\u5192\u5f8c\u55c5\u899a\u5473\u899a\u969c\u5bb3\u4f8b\u3000\u7b2c51\u56de\u65e5\u672c\u9f3b\u79d1\u5b66\u4f1a\u30009\/27-29\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                   32. \u9577\u4e95\u4eca\u65e5\u5b50\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u5c0f\u5150\u4eba\u5de5\u5185\u8033\u88c5\u7528\u5150\u306b\u5bfe\u3059\u308b\u4e2d\u8033\u708e\u3068\u305d\u306e\u95a2\u9023\u75be\u60a3\u3078\u306e\u5bfe\u51e6\u3000\u7b2c22\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300010\/4-6\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                                   33. \u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u4e21\u5074\u5185\u8033\u9053\u306b\u8a8d\u3081\u3089\u308c\u305f\u9ac4\u819c\u764c\u816b\u75c7\u306e2\u75c7\u4f8b<\/li>\n
                                   34. \u6751\u7530\u8003\u5553\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u6d3b\u52d5\u6027\u4e2d\u8033\u708e\u3092\u4f34\u3046\u807e\u75c7\u4f8b\u3078\u306e\u6bb5\u968e\u7684\u4eba\u5de5\u5185\u8033\u57cb\u3081\u8fbc\u307f\u8853\u3000\u7b2c22\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300010\/4-6\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                                   35. \u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u897f\u3000\u660e\u3001\u3000\u6751\u7530\u8003\u5553\u3001\u6a2a\u5800\u6709\u7d00\u3001\u5c0f\u539f\u900f\u3001\u7be0\u539f\u60a0\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u5148\u5929\u6027\u6a2a\u9694\u819c\u30d8\u30eb\u30cb\u30a2\u306e\u65e2\u5f80\u304c\u3042\u308b\u96e3\u8074\u5150\uff17\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c57\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/11-12\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                   36. \u9577\u4e95\u4eca\u65e5\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u5c0f\u539f\u900f\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6a2a\u5800\u6709\u7d00\u3001\u7be0\u539f\u60a0\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3001\u6c34\u8c37\u6e05\u9686\u3000\u91cd\u5ea6\u96e3\u8074\u7528\u30c7\u30b8\u30bf\u30eb\u88dc\u8074\u5668\uff08Naida\uff09\u306b\u304a\u3051\u308b\u5468\u6ce2\u6570\u5727\u7e2e\u5909\u63db\u6a5f\u80fd\u306e\u52b9\u679c\u3000\u7b2c57\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/11-12\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                   37. \u5bae\u5d0e\u3000\u9054\u4e5f\u3001\u732a\u702c\u3000\u5d07\u5fb3\u3001\u7530\u4e2d\u3000\u6210\u5cb3\u3001\u9234\u6728\u3000\u8302\u6b63\u3001\u6a2a\u5800\u3000\u6b66\u5f66\u3001\u5c0f\u6fa4\u3000\u5927\u609f\u3001\u539f\u3000\u572d\u543e\u3001\u6a2a\u5c71\u3000\u6d0b\u4e09\u3001\u798f\u5730\u3000\u7a14\u3001\u6839\u5cb8\u3000\u660e\u79c0\u3001\u6a2a\u5c3e\u3000\u8061\u3001\u8c4a\u7530\u3000\u5b9f\u3001\u8fd1\u677e\u3000\u4e00\u6717\u3001\u52a0\u85e4\u3000\u5e83\u884c\u3001\u6851\u91ce\u3000\u535a\u884c\u3000\u30b9\u30da\u30b7\u30e3\u30ea\u30b9\u30c8\u306e\u529b\u3092\u96c6\u7d50\u3057\u305f\u98df\u9053\u764c\u8a3a\u7642\u306e\u65b0\u5c55\u958b\u3000\u7b2c64\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u3000\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300011\/8\u3000\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                                   38. \u8c4a\u7530\u3000\u5b9f\u3001\u5b89\u5ca1\u3000\u7fa9\u4eba\u3001\u5ca1\u5bae\u3000\u667a\u53f2\u3001\u5cf6\u7530\u3000\u54f2\u660e\u3001\u52a0\u5bb6\u58c1\u3000\u7f8e\u6a39\u5b50\u3001\u6751\u7530\u3000\u8003\u5553\u3001\u7d2b\u91ce\u3000\u6b63\u4eba\u3001\u8fd1\u677e\u3000\u4e00\u6717\u3000\u4e73\u5e7c\u5150\u306e\u6c17\u7ba1\u958b\u7a93\u8853\u306e\u4e00\u5de5\u592b\u3000\u7b2c64\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u3000\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300011\/8\u3000\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                                   39. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7121\u9178\u7d20\u7121\u30b0\u30eb\u30b3\u30fc\u30b9\u523a\u6fc0\u306b\u3088\u308bNMDA\u53d7\u5bb9\u4f53\u3092\u4ecb\u3057\u305f\u524d\u5ead\u5c0f\u8133unipolar brush cell \u306e\u81ea\u767a\u767a\u706b\u306e\u5897\u5f37\u3000\u7b2c71\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/29\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                                   40. \u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u5074\u524d\u5ead\u795e\u7d4c\u6838\u30cb\u30e5\u30fc\u30ed\u30f3\u306e\u30bf\u30a4\u30d7\u306b\u3088\u308b\u865a\u8840\u306b\u5bfe\u3059\u308b\u53cd\u5fdc\u306e\u5dee\u7570\u3000\u7b2c71\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/29\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                                   41. \u5bae\u4e0b\u5143\u660e\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u65b9\u5411\u4ea4\u4ee3\u6027\u4e0b\u5411\u6027\u982d\u4f4d\u773c\u632f\u3092\u8a8d\u3081\u305f\u975e\u5185\u8033\u6027\u3081\u307e\u3044\u75c7\u4f8b\u3000\u7b2c71\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/29\uff08\u6771\u4eac\u90fd\uff09<\/li>\n
                                   42. \u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u6a2a\u5800\u6709\u7d00\u3001\u5c0f\u539f\u3000\u900f\u3001\u7be0\u539f\u60a0\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3001\u897f\u3000\u660e\uff08\u770c\u7acb\u5c0f\u5150\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u3000\u5916\u79d1\uff09\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u5148\u5929\u6027\u6a2a\u9694\u819c\u30d8\u30eb\u30cb\u30a2\u306e\u65e2\u5f80\u304c\u3042\u308b\u96e3\u8074\u51507\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300012\/9\u3000\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   43. \u5cf6\u7530\u54f2\u660e\u3001\u661f\u91ce\u3000\u7adc\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5473\u899a\u969c\u5bb3\u60a3\u8005\u306b\u304a\u3051\u308b\u8840\u6e05\u4e9c\u925b\u5024\u306e\u5909\u52d5\u3068\u5473\u899a\u8a8d\u77e5\u95be\u5024\u306e\u691c\u8a0e\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300012\/9\u3000\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   44. \u9ad8\u6a4b\u514b\u660c\u3001\u5bae\u4e0b\u5143\u660e\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5e83\u7fa9\u306e\u7279\u767a\u6027\u5916\u30ea\u30f3\u30d1\u763b3\u75c7\u4f8b\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300012\/9\u3000\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   45. \u5b89\u5ca1\u7fa9\u4eba\uff08\u9db4\u8c37\uff09\u3001\u7b39\u6751\u4f73\u7f8e\uff08\u81ea\u6cbb\u533b\u79d1\u5927\u5b66\u3068\u3061\u304e\u5b50\u3069\u3082\u533b\u7642\u30bb\u30f3\u30bf\u30fc\uff09\u3001\u5e02\u6751\u6075\u4e00\uff08\u81ea\u6cbb\u533b\u79d1\u5927\u5b66\uff09\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u524d\u9838\u90e8\u6709\u830e\u7b4b\u76ae\u5f01\u3092\u7528\u3044\u305f\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5\uff09\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300012\/9\u3000\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   46. \u6a2a\u5800\u6709\u7d00\u3001\u8c4a\u7530\u3000\u5b9f\u3001 \u5742\u5009\u6d69\u4e00\u3001\u8fd1\u677e\u4e00\u6717\u3001\u89e3\u697d\u606d\u4e00\uff08\u816b\u760d\u30bb\u30f3\u30bf\u30fc\uff09\u3000MAX suv\u306e\u53e3\u8154\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u751f\u7269\u5b66\u7684\u610f\u7fa9\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u300012\/9\u3000\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                   47. \u5cf6\u7530\u3000\u54f2\u660e\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u4e8c\u5bae\u6d0b\u3001\u98ef\u7530\u82f1\u57fa\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u80f8\u9aa8\u820c\u9aa8\u7b4b\u306b\u3088\u308b\u727d\u5f15\u3092\u8ffd\u52a0\u3057\u305f\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS\/SHM-pull\uff09\u7b2c\uff12\uff13\u56de\u65e5\u672c\u982d\u9838\u90e8\u5916\u79d1\u5b66\u4f1a\u30001\/24-25(\u9e7f\u5150\u5cf6\u5e02)<\/li>\n
                                   48. \u5742\u5009\u6d69\u4e00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u764c\u6297\u539fCSPG4\u3092\u6a19\u7684\u3068\u3057\u305f\u982d\u9838\u90e8\u764c\u306b\u5bfe\u3059\u308b\u514d\u75ab\u7642\u6cd5\u306e\u53ef\u80fd\u6027\u3000\u7b2c31\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u30002\/7-9\uff08\u5009\u6577\u5e02\uff09<\/li>\n
                                   49. \u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5bfe\u7167\u7684\u306a\u7d4c\u904e\u3092\u8fbf\u3063\u305f\u9ac4\u819c\u764c\u816b\u75c7\u306e2\u75c7\u4f8b\u3000\u7b2c103\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a(\u524d\u6a4b\u5e02)<\/li>\n
                                   50. \u5cf6\u7530\u54f2\u660e\u3001\u661f\u91ce \u7adc\u3001\u5bcc\u6fa4\u7d18\u6075\u3001\u938c\u7530\u82f1\u7537\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5473\u899a\u969c\u5bb3\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305f\u80f8\u817a\u816b\u306e\u4e00\u4f8b\u3000\u7b2c103\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a(\u524d\u6a4b\u5e02)<\/li>\n
                                   51. \u9577\u4e95\u4eca\u65e5\u5b50\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u6a2a\u5800\u6709\u7d00\u3001\u8fd1\u677e\u4e00\u6717\u3000\u690e\u539f\u9686\uff08\u770c\u7acb\u5c0f\u5150\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u30fb\u795e\u7d4c\u5185\u79d1\uff09Pelizaeus-Merzbacher\u75c5\u306e\u8074\u529b\u7d4c\u904e\u3000\u7b2c103\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a(\u524d\u6a4b\u5e02)<\/li>\n
                                   52. \u6751\u7530\u8003\u5553\u3001\u5cf6\u7530\u54f2\u660e\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5b89\u5ca1\u7fa9\u4eba\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u3092\u7528\u3044\u305f\u97f3\u58f0\u6539\u5584\u624b\u8853\u306b\u3088\u308b\u97f3\u58f0\u969c\u5bb3\u306e\u81ea\u899a\u7684\u8a55\u4fa1\u3078\u306e\u5f71\u97ff\u3000\u7b2c103\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a(\u524d\u6a4b\u5e02)<\/li>\n
                                   53. \u5b89\u5ca1\u7fa9\u4eba\uff08\u9db4\u8c37\uff09\u3001\u5b88\u672c\u502b\u5b50\uff08\u6210\u80b2\u533b\u7642\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u30fb\u8033\u9f3b\u54bd\u5589\u79d1\uff09\u76ca\u7530\u614e\uff08\u770c\u7acb\u5e83\u5cf6\u75c5\u9662\u30fb\u5c0f\u5150\u611f\u899a\u5668\u79d1\uff09\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u8f2a\u72b6\u5f8c\u90e8\u5f62\u6210\u8853\u304c\u594f\u529f\u3057\u305f\u5c0f\u5150\u58f0\u9580\u5f8c\u90e8\u72ed\u7a84\u75c7\uff08PGS\uff09\u306e2\u75c7\u4f8b\u3000\u7b2c103\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a(\u524d\u6a4b\u5e02)<\/li>\n
                                   54. \u6751\u7530\u8003\u5553\u3001\u5cf6\u7530\u54f2\u660e\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u3092\u7528\u3044\u305f\u97f3\u58f0\u6539\u5584\u624b\u8853\u306b\u3088\u308b\u97f3\u58f0\u969c\u5bb3\u306e\u81ea\u899a\u7684\u8a55\u4fa1\u3078\u306e\u5f71\u97ff\u3000\u7b2c25\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/7-8(\u6a2a\u6d5c\u5e02)<\/li>\n<\/ol>\n

                                        <\/p>\n

                                       \u5b66\u4f1a\u767a\u8868\uff082011\u5e74\u5ea6\uff09<\/h1>\n

                                       \n
                                       1. \u98ef\u7530\u82f1\u57fa\u3000\u7532\u72b6\u817a\u764c\u304c\u7591\u308f\u308c\u305f\u8f2a\u72b6\u8edf\u9aa8\u539f\u767a\u5589\u982d\u8edf\u9aa8\u8089\u816b\u306e\u4e00\u4f8b\u3000\u7b2c23\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30004\/21-22\uff08\u65ed\u5ddd\u5e02\uff09<\/li>\n
                                       2. \u6751\u7530\u8003\u5553\u3000\u58f0\u9580\u4e0b\u795e\u7d4c\u9798\u816b\u306e\u4e00\u4f8b\u3000\u7b2c23\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30004\/21-22\uff08\u65ed\u5ddd\u5e02\uff09<\/li>\n
                                       3. \u5cf6\u7530\u54f2\u660e, \u5ca1\u5bae\u667a\u53f2, \u5bae\u4e0b\u5143\u660e, \u938c\u7530\u82f1\u7537, \u53e4\u5c4b\u4fe1\u5f66 NBI\u3092\u7528\u3044\u305f\u8338\u72b6\u4e73\u982d\u6570\u304a\u3088\u3073\u4e73\u982d\u6d41\u5165\u8840\u7ba1\u306e\u89b3\u5bdf\u00a0 \u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       4. \u6751\u7530\u8003\u5553, \u5cf6\u7530\u54f2\u660e, \u7d2b\u91ce\u6b63\u4eba, \u98ef\u7530\u82f1\u57fa, \u5b89\u5ca1\u7fa9\u4eba \u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u306e\u8853\u5f0f\u3068\u6cbb\u7642\u6210\u7e3e\u00a0 \u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       5. \u5b89\u5ca1\u7fa9\u4eba, \u9577\u4e95\u4eca\u65e5\u5b50, \u9ad8\u5b89\u5e78\u5f18, \u7d2b\u91ce\u6b63\u4eba, \u9ad8\u6a4b\u514b\u660c, \u53e4\u5c4b\u4fe1\u5f66\u3000\u3000\u5c0f\u8033\u75c7\u30fb\u5916\u8033\u9053\u9589\u9396\u75c7\u306b\u5bfe\u3059\u308b\u8584\u5207\u8edf\u9aa8\u3092\u7528\u3044\u305f\u5916\u8033\u9053\u30fb\u9f13\u5ba4\u5f62\u6210\u8853(MT-TSC)\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       6. \u9ad8\u6a4b\u514b\u660c, \u9ad8\u5b89\u5e78\u5f18, \u5de5\u85e4\u6bc5, \u7d2b\u91ce\u6b63\u4eba, \u4e2d\u5cf6\u606d\u5b50, \u5ddd\u7530\u502b\u4e4b, \u677e\u5c71\u654f\u4e4b, \u53e4\u5c4b\u4fe1\u5f66 OSNA\u6cd5\u306b\u3088\u308b\u8ee2\u79fb\u30ea\u30f3\u30d1\u7bc0\u306e\u8fc5\u901f\u8a3a\u65ad\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       7. \u6751\u7530\u8003\u5553, \u5cf6\u7530\u54f2\u660e, \u7d2b\u91ce\u6b63\u4eba, \u98ef\u7530\u82f1\u57fa, \u5b89\u5ca1\u7fa9\u4eba\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u306e\u8853\u5f0f\u3068\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       8. \u7d2b\u91ce\u6b63\u4eba, \u5b89\u5ca1\u7fa9\u4eba, \u4e8c\u5bae\u6d0b, \u98ef\u7530\u82f1\u57fa, \u6751\u7530\u8003\u5553, \u8c4a\u7530\u5b9f, \u53e4\u5c4b\u4fe1\u5f66\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853(\u6c17\u7ba1\u5f01\u6cd5)\u3068\u6c17\u7ba1\u5207\u958b\u60a3\u8005\u3078\u306e\u5fdc\u7528\u3000\u7b2c102\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30005\/19-21\uff08\u4eac\u90fd\u5e02\uff09<\/li>\n
                                       9. \u7d2b\u91ce\u6b63\u4eba\u3001\u6751\u7530\u8003\u5553\u3001\u98ef\u7530\u82f1\u57fa\u3001\u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u53e4\u5c4b\u4fe1\u5f66\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u30a2\u30f3\u30ae\u30aa\u30c6\u30f3\u30b7\u30f3\u2161\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u306b\u3088\u308b \u8840\u7ba1\u6d6e\u816b\u306e\u4e00\u4f8b\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       10. \u5cf6\u7530\u54f2\u660e\u3001\u938c\u7530\u82f1\u7537\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000NBI\u3092\u7528\u3044\u305f\u820c\u4e73\u982d\u89b3\u5bdf\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       11. \u5ca1\u672c\u5f69\u5b50\u3001\u9234\u6728\u653f\u7f8e\u3001\u5de5\u85e4\u6bc5\u3001\u5ca1\u7530\u9686\u5e73 (\u304c\u3093\u30bb\u30f3\u30bf\u30fc)\u3001\u8c4a\u7530\u5b9f\u3000\u591a\u767a\u6027\u5bfe\u79f0\u6027\u8102\u80aa\u816b\u75c7\u306e2\u4f8b\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       12. \u5ca1\u5bae\u667a\u53f2\u3001\u98ef\u7530\u82f1\u57fa\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u5148\u5929\u6027\u771f\u73e0\u816b20\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       13. \u98ef\u7530\u82f1\u57fa\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u53e4\u5c4b\u4fe1\u5f66\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u7532\u72b6\u817a\u764c\u304c\u7591\u308f\u308c\u305f\u8f2a\u72b6\u8edf\u9aa8\u539f\u767a\u5589\u982d\u8edf\u9aa8\u8089\u816b\u306e1\u4f8b\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       14. \u4e09\u30c4\u6751\u4e00\u6d69\u3001\u4e95\u4e0a\u8cb4\u6d0b\u3001\u6afb\u4e95\u52aa\uff08\u4f0a\u52e2\u5d0e\u5e02\u6c11\uff09\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u5de5\u85e4\u6bc5\u3001\u8c4a\u7530\u5b9f\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u5c0f\u5150\u306b\u767a\u751f\u3057\u305f\u8033\u4e0b\u817a\u7c98\u8868\u76ae\u764c\u306e1\u4f8b\u3000\u7b2c98\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u30006\/5\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       15. \u677e\u5c71\u654f\u4e4b, \u9577\u4e95\u4eca\u65e5\u5b50, \u9ad8\u5b89\u5e78\u5f18, \u4e2d\u5cf6\u606d\u5b50, \u6751\u7530\u8003\u5553, \u8352\u5ddd\u6d69\u4e00, \u5b89\u5ca1\u7fa9\u4eba\u3000\u3000\u4e21\u5074\u6025\u6027\u91cd\u5ea6\u96e3\u8074\u3092\u751f\u3058\u305f\u30e0\u30f3\u30d7\u30b9\u611f\u67d3\u306e1\u75c7\u4f8b \u7b2c6\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/16-17\u3000\uff08\u3055\u3044\u305f\u307e\u5e02\uff09<\/li>\n
                                       16. \u4e2d\u5cf6\u606d\u5b50, \u5de5\u85e4\u6bc5, \u9577\u4e95\u4eca\u65e5\u5b50, \u5b89\u5ca1\u7fa9\u4eba\u3000\u3000\u5c0f\u5150\u5b8c\u5168\u5074\u9838\u763b\u306e1\u75c7\u4f8b\u3000\u7b2c6\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/16-17\u3000\uff08\u3055\u3044\u305f\u307e\u5e02\uff09<\/li>\n
                                       17. \u9577\u4e95\u4eca\u65e5\u5b50, \u5b89\u5ca1\u7fa9\u4eba, \u7d2b\u91ce\u6b63\u4eba, \u5ddd\u7530\u502b\u4e4b, \u4e2d\u5cf6\u606d\u5b50, \u677e\u5c71\u654f\u884c\u3000\u3000\u51fa\u8840\u6027\u9f3b\u54bd\u8154\u816b\u760d\u306b\u5bfe\u3059\u308b\u5185\u8996\u93e1\u4e0b\u786c\u5316\u7642\u6cd5\u3000\u7b2c6\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/16-17\u3000\uff08\u3055\u3044\u305f\u307e\u5e02\uff09<\/li>\n
                                       18. \u5b89\u5ca1\u7fa9\u4eba, \u4e8c\u5bae\u6d0b, \u7d2b\u91ce\u6b63\u4eba, \u6751\u7530\u8003\u5553, \u98ef\u7530\u82f1\u57fa, \u9577\u4e95\u4eca\u65e5\u5b50, \u6e21\u8fba\u7f8e\u7dd2, \u8352\u5ddd\u6d69\u4e00\u3000\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853(\u6c17\u7ba1\u5f01\u6cd5)\u306e\u8853\u5f0f\u3068\u305d\u306e\u5229\u70b9\u3000\u7b2c6\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/16-17\u3000\uff08\u3055\u3044\u305f\u307e\u5e02\uff09<\/li>\n
                                       19. \u9ad8\u6a4b\u79c0\u884c, \u9577\u4e95\u4eca\u65e5\u5b50, \u98ef\u7530\u82f1\u57fa, \u767b\u5742\u96c5\u5f66, \u5b89\u5ca1\u7fa9\u4eba, \u53e4\u5c4b\u4fe1\u5f66\u3000\u3000\u53cd\u5fa9\u6027\u9ac4\u819c\u708e\u3092\u5408\u4f75\u3057\u305f\u5185\u8033\u5947\u5f62\u75c7\u4f8b\u3000\u7b2c6\u56de\u65e5\u672c\u5c0f\u5150\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u30006\/16-17\u3000\uff08\u3055\u3044\u305f\u307e\u5e02\uff09<\/li>\n
                                       20. \u938c\u7530\u82f1\u7537, \u5cf6\u7530\u54f2\u660e, \u53e4\u5c4b\u4fe1\u5f66\u3000\u5916\u50b7\u5f8c\u5473\u899a\u969c\u5bb3\u3001\u55c5\u899a\u969c\u5bb3\u75c7\u4f8b\u3000\u7b2c24\u56de\u65e5\u672c\u53e3\u8154\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/8-9\uff08\u5e83\u5cf6\u5e02\uff09<\/li>\n
                                       21. \u5cf6\u7530\u54f2\u660e, \u938c\u7530\u82f1\u7537 NBI\u3092\u7528\u3044\u305f\u30b3\u30f3\u30bf\u30af\u30c8\u30a8\u30f3\u30c9\u30b9\u30b3\u30fc\u30d7\u306b\u3088\u308b\u820c\u4e73\u982d\u89b3\u5bdf\u3000\u7b2c24\u56de\u65e5\u672c\u53e3\u8154\u54bd\u982d\u79d1\u5b66\u4f1a\u30009\/8-9\uff08\u5e83\u5cf6\u5e02\uff09<\/li>\n
                                       22. \u8fd1\u677e\u4e00\u6717(\u5c71\u68a8\u5927\u5b66 \u533b\u30fb\u8033), \u5742\u5009\u6d69\u4e00\u3000\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u60a3\u8005\u306b\u304a\u3051\u308b\u5358\u7403\u7cfbmyeloid-derived suppressor cells\u306e\u514d\u75ab\u6291\u5236\u306b\u679c\u305f\u3059\u5f79\u5272(Immunosuppressive role of mono cytic myeloid- derived suppressor cells in patients with head and neck cancer)\u3000\u7b2c70\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u300010\/3-5\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                                       23. \u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u57f4\u7530\u60a0\u5b50\uff0c\u6885\u672c\u548c\u6b63\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\u3000\u5e83\u6c4e\u6027\u767a\u9054\u969c\u5bb3\u75c7\u4f8b\u306b\u304a\u3051\u308b\u8074\u6027\u5b9a\u5e38\u53cd\u5fdc\u306e\u7279\u6027\u3000\u7b2c56\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/27-28(\u798f\u5ca1\u5e02)<\/li>\n
                                       24. \u57f4\u7530\u60a0\u5b50\uff0c\u5c0f\u539f\u900f\uff0c\u6751\u7530\u8003\u5553\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6885\u672c\u548c\u6b63\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\u3000\u7fa4\u99ac\u770c\u306b\u304a\u3051\u308b\u65b0\u751f\u5150\u8074\u899a\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u304a\u3051\u308brefer \u5150\u306e\u73fe\u6cc1\uff08\u7b2c\u4e8c\u5831\uff09\u3000\u7b2c56\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/27-28(\u798f\u5ca1\u5e02)<\/li>\n
                                       25. \u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u5c0f\u539f\u900f\uff0c\u57f4\u7530\u60a0\u5b50\uff0c\u6885\u672c\u548c\u6b63\u3000\u4eba\u5de5\u5185\u8033\u88c5\u7528\u5150\u306e\u5b66\u6821\u751f\u6d3b\u306b\u304a\u3051\u308b\u805e\u3053\u3048\u306e\u5b9f\u614b\u3068\u652f\u63f4\u4f53\u5236\u3000\u7b2c56\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/27-28(\u798f\u5ca1\u5e02)<\/li>\n
                                       26. \u5c0f\u539f\u900f\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u57f4\u7530\u60a0\u5b50\uff0c\u4e2d\u5cf6\u606d\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u6885\u672c\u548c\u6b63\u3000\uff11\u6b73\u4ee5\u964d\u306b\u5f53\u79d1\u3092\u53d7\u8a3a\u3057\u305f\u96e3\u8074\u5150\u306e\u5b9f\u614b\u8abf\u67fb\u3000\u7b2c56\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/27-28(\u798f\u5ca1\u5e02)<\/li>\n
                                       27. \u4e2d\u5cf6\u606d\u5b50\uff0c\u9577\u4e95\u4eca\u65e5\u5b50\uff0c\u6751\u7530\u8003\u5553\uff0c\u57f4\u7530\u60a0\u5b50\uff0c\u5c0f\u539f\u900f\u3000Axenfeld \u5947\u5f62\u306b\u5185\u8033\u30fb\u4e2d\u8033\u5947\u5f62\u306b\u3088\u308b\u96e3\u8074\u3092\u4f34\u3063\u305f\uff11\u5bb6\u7cfb\u3000\u7b2c56\u56de\u65e5\u672c\u8074\u899a\u533b\u5b66\u4f1a\u300010\/27-28(\u798f\u5ca1\u5e02)<\/li>\n
                                       28. \u5cf6\u7530\u54f2\u660e, \u6751\u7530\u8003\u5553, \u5de5\u85e4\u6bc5, \u7d2b\u91ce\u6b63\u4eba, \u98ef\u7530\u82f1\u57fa, \u5b89\u5ca1\u7fa9\u4eba, \u53e4\u5c4b\u4fe1\u5f66 \u6458\u51fa\u5589\u982d\u306b\u3088\u308b\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\u00a0 \u7b2c63\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a\u300011\/10-11\uff08\u540d\u53e4\u5c4b\u5e02\uff09<\/li>\n
                                       29. \u6751\u7530\u8003\u5553, \u5ddd\u7530\u502b\u4e4b, \u7d2b\u91ce\u6b63\u4eba, \u98ef\u7530\u82f1\u57fa, \u5b89\u5ca1\u7fa9\u4eba\u3000\u3000\u56a5\u4e0b\u6027\u80ba\u708e\u3068\u5589\u982d\u8edf\u5f31\u75c7\u3092\u5408\u4f75\u3057\u305f\u5589\u982d\u88c2\u306e1\u75c7\u4f8b\u3000\u7b2c63\u56de\u65e5\u672c\u6c17\u7ba1\u98df\u9053\u79d1\u5b66\u4f1a<\/li>\n
                                       30. \u5bae\u4e0b\u5143\u660e\u3001\u677e\u5c71\u654f\u4e4b\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u9ad8\u6a4b\u514b\u660c\u3000\u3081\u307e\u3044\u3092\u4e3b\u8a34\u306b\u591a\u767a\u8133\u795e\u7d4c\u969c\u5bb3\u3092\u5448\u3057\u305fRamsay Hunt\u75c7\u5019\u7fa4\u306e\uff11\u4f8b\u3000\u7b2c70\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/16-18\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                       31. \u9ad8\u5b89\u5e78\u5f18\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u524d\u5ead\u5c0f\u8133unipolar brush cell \u306b\u304a\u3051\u308b\u767a\u706b\u7279\u5fb4\u3068\u7121\u9178\u7d20\u7121\u30b0\u30eb\u30b3\u30fc\u30b9\u523a\u6fc0\u306b\u5bfe\u3059\u308b\u611f\u53d7\u6027\u3000\u7b2c70\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/16-18\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                       32. \u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u5bae\u4e0b\u5143\u660e\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u53e4\u5c4b\u4fe1\u5f66\u3000\u865a\u8840\u306b\u3088\u308b\u5185\u5074\u524d\u5ead\u795e\u7d4c\u6838\u30cb\u30e5\u30fc\u30ed\u30f3\u306e\u4e00\u904e\u6027\u904e\u5206\u6975\u3092\u8aac\u660e\u3059\u308bATP\u611f\u53d7\u6027K\u30c1\u30e3\u30cd\u30eb\u7531\u6765\u306e\u5916\u5411\u304d\u30ab\u30ea\u30a6\u30e0\u96fb\u6d41\u3000\u7b2c70\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/16-18\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                       33. \u9ad8\u6a4b\u514b\u660c\u3001\u677e\u5c71\u654f\u4e4b\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u5bae\u4e0b\u5143\u660e\u3000\u932f\u8996\u56f3\u5f62\u3068\u8996\u6027\u81ea\u899a\u7684\u5782\u76f4\u4f4d\u3000\u7b2c70\u56de\u65e5\u672c\u3081\u307e\u3044\u5e73\u8861\u533b\u5b66\u4f1a\u300011\/16-18\uff08\u5343\u8449\u5e02\uff09<\/li>\n
                                       34. \u9577\u4e95\u4eca\u65e5\u5b50, \u6751\u7530\u8003\u5553, \u4e2d\u5cf6\u606d\u5b50, \u5ca1\u5bae\u667a\u53f2, \u5b89\u5ca1\u7fa9\u4eba, \u53e4\u5c4b\u4fe1\u5f66 \u4eba\u5de5\u5185\u8033\u57cb\u3081\u8fbc\u307f\u8853\u3092\u65bd\u884c\u3057\u305f\u7b2c1\u3001\u7b2c2\u9c13\u5f13\u75c7\u5019\u7fa41\u4f8b\u3000\u7b2c21\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300011\/24-25\uff08\u6c96\u7e04\u5e02\uff09<\/li>\n
                                       35. \u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3000\u5f53\u79d1\u306b\u304a\u3051\u308b\u96e3\u8074\u3092\u5408\u4f75\u3057\u305f\u5e83\u6c4e\u6027\u767a\u9054\u969c\u5bb3\u75c7\u4f8b\u306e\u691c\u8a0e\u3000\u7b2c21\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300011\/24-25\uff08\u6c96\u7e04\u5e02\uff09<\/li>\n
                                       36. \u5ca1\u5bae\u667a\u53f2\u3001\u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3000\u8133\u8868\u30d8\u30e2\u30b8\u30c7\u30ea\u30f3\u6c88\u7740\u75c7\u306e1\u75c7\u4f8b\u3000\u7b2c21\u56de\u65e5\u672c\u8033\u79d1\u5b66\u4f1a\u300011\/24-25\uff08\u6c96\u7e04\u5e02\uff09<\/li>\n
                                       37. \u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u98ef\u7530\u82f1\u57fa\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u91cd\u8907\u763b\u7ba1\u304c\u7591\u308f\u308c\u305f\u4e0b\u54bd\u982d\u68a8\u72b6\u9665\u51f9\u763b\u306e\uff11\u4f8b\u3000\u7b2c99\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/11\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       38. \u98ef\u7530\u82f1\u57fa\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u6fa4\u6d66\u6cd5\u5b50\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\u5f8c\u306b\u8155\u982d\u52d5\u8108\u96e2\u65ad\u8853\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b\u3000\u7b2c99\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/11\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       39. \u5b89\u5ca1\u7fa9\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u5ca1\u5bae\u667a\u53f2\u3001\u9ad8\u6a4b\u514b\u660c\u3001\u8fd1\u677e\u4e00\u6717\u3000\u9f3b\u51fa\u8840\u6b62\u8840\u6cd5\u306e\u4e00\u5de5\u592b\u3000\u7b2c99\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/11\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       40. \u4e2d\u5cf6\u606d\u5b50\u3001\u6751\u7530\u8003\u5553\u3001\u5c0f\u539f\u900f\u3001\u57f4\u7530\u60a0\u5b50\u3001\u6885\u672c\u548c\u6b63\u3001\u9577\u4e95\u4eca\u65e5\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000Axenfeld\u5947\u5f62\u306b\u96e3\u8074\u3092\u4f34\u3063\u305f\uff11\u5bb6\u7cfb\u3000\u7b2c99\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/11\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       41. \u9577\u4e95\u4eca\u65e5\u5b50\u3001\u5c0f\u539f\u900f\u3001\u57f4\u7530\u60a0\u5b50\u3001\u6885\u672c\u548c\u6b63\u3001\u6751\u7530\u8003\u5553\u3001\u4e2d\u5cf6\u606d\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u4eba\u5de5\u5185\u8033\u88c5\u7528\u5150\u306e\u7642\u80b2\u4f53\u5236\u3068\u8a00\u8a9e\u767a\u9054\u3000\u7b2c99\u56de\u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u7fa4\u99ac\u770c\u5730\u65b9\u90e8\u4f1a\u300012\/11\uff08\u524d\u6a4b\u5e02\uff09<\/li>\n
                                       42. \u5cf6\u7530\u54f2\u660e\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u98ef\u7530\u82f1\u57fa\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS\uff09\u306e\u624b\u8853\u624b\u6280\u3068\u624b\u8853\u306e\u30b3\u30c4\u3000\u7b2c22\u56de\u65e5\u672c\u982d\u9838\u90e8\u5916\u79d1\u5b66\u4f1a\u30001\/26-27\uff08\u798f\u5cf6\u5e02\uff09<\/li>\n
                                       43. \u5b89\u5ca1\u7fa9\u4eba\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u4e8c\u5bae\u6d0b\u3001\u6751\u7530 \u8003\u5553\u3001\u98ef\u7530\u82f1\u57fa\u3001\u5343\u4ee3\u7530\u670b\u5b50\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5A\u30fbB\u30fbC-type\uff09\u306e\u8853\u5f0f\u30fb\u9069\u5fdc\u30fb\u5229\u70b9\u3000\u7b2c35\u56de\u65e5\u672c\u56a5\u4e0b\u533b\u5b66\u4f1a\u30002\/10-11\uff08\u9ad8\u77e5\u5e02\uff09<\/li>\n
                                       44. \u7d2b\u91ce\u6b63\u4eba\u3001\u5b89\u5ca1\u7fa9\u4eba\u3001\u4e8c\u5bae\u6d0b\u3001\u6751\u7530 \u8003\u5553\u3001\u5343\u4ee3\u7530\u670b\u5b50\u3001\u98ef\u7530\u82f1\u57fa\u3001\u8c4a\u7530\u5b9f\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5589\u982d\u6c17\u7ba1\u5206\u96e2\u8853\uff08\u6c17\u7ba1\u5f01\u6cd5A\u30fbB\u30fbC-type\uff09\u306e\u624b\u8853\u3068\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c24\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/8-9\uff08\u91d1\u6ca2\u5e02\uff09<\/li>\n
                                       45. \u5b89\u5ca1\u7fa9\u4eba\u3001\u5cf6\u7530\u54f2\u660e\u3001\u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u8c4a\u7530\u5b9f\u3001\u98ef\u7530\u82f1\u57fa\u3001\u9ad8\u5b89\u5e78\u5f18\u3001\u8fd1\u677e\u4e00\u6717\u3000\u5185\u8996\u93e1\u4e0b\u62ab\u88c2\u8edf\u9aa8\u5185\u8ee2\u8853\uff08EAAS\uff09\u306e\u65b9\u6cd5\u3068\u624b\u8853\u306e\u30b3\u30c4\u3000\u7b2c24\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/8-9\uff08\u91d1\u6ca2\u5e02\uff09<\/li>\n
                                       46. \u6751\u7530\u8003\u5553\u3001\u7d2b\u91ce\u6b63\u4eba\u3001\u98ef\u7530\u82f1\u57fa\u3001\u5b89\u5ca1\u7fa9\u4eba\u3000\u56a5\u4e0b\u6027\u80ba\u708e\u3068\u5589\u982d\u8edf\u5f31\u75c7\u3092\u5408\u4f75\u3057\u305f\u5589\u982d\u88c2\u306e\uff11\u75c7\u4f8b\u3000\u7b2c24\u56de\u65e5\u672c\u5589\u982d\u79d1\u5b66\u4f1a\u30003\/8-9\uff08\u91d1\u6ca2\u5e02\uff09<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                                           \u8ad6\u6587\uff082026\uff09 Takahashi H, Rokudai S, Chikamatsu K.\u00a0Methods to identify and validate therapeutic targets against ca […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2,"menu_order":24,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1924","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/1924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1924"}],"version-history":[{"count":133,"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/1924\/revisions"}],"predecessor-version":[{"id":5481,"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/1924\/revisions\/5481"}],"up":[{"embeddable":true,"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/2"}],"wp:attachment":[{"href":"https:\/\/jibika.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}